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I 
Abstract 
The past years of research have clearly demonstrated that the interaction of genetic, 
environmental and epigenetic factors contribute to the individual variation of the 
vulnerability to stress, anxiety and depression and finally up to the manifestation of 
psychopathology.  
This study focused on the impact of gene x environment interactions on anxiety-
related and depression-like behaviors and neurogenesis. Therefore, we used a well-
established mouse model, selectively bred for anxiety-related behavior, which 
represents two extremes: high (HAB) vs. low (LAB) anxiety-related behavior. To shift 
the two extreme genetic predispositions towards ‘normal’ behavior, the environment 
of HAB mice was manipulated in a beneficial way via enriched environment (EE) and 
the environment of LAB mice in an adverse manner via exposure to chronic mild 
stress (CMS). EE offered the HAB mice a pleasant, complex environmental setup, 
which is reflected in reduced anxiety, as assessed in different behavioral tests. In 
contrast, CMS induced anxiogenic effects and more depression-like behavior in LAB 
mice. As repeatedly shown for this mouse model, the amygdala, particularly its 
basolateral nucleus (BLA), is crucially involved in the regulation of anxiety. Thus, we 
selected the BLA to test the genetic influences of environmental manipulations in a 
‘for better and for worse manner’ by performing a microarray-based gene expression 
profiling, covering the whole genome, of HAB, HAB-EE, LAB and LAB-CMS animals. 
Importantly, the same candidate genes that were shown to be differentially 
expressed between HAB and LAB animals in a microarray analysis of animals 20 
generations before were detected, thereby providing strong evidence for a fixed 
genetic background of the extremes in anxiety-related behavior. In our genome-wide 
expression assay, we could identify three potential candidate genes, confirmed by 
qPCR in an independent set of samples, which were differentially expressed in HAB 
vs. HAB-EE (Fos, Gabrq) or LAB vs. LAB-CMS (Cnksr2) mice. Furthermore, we 
assessed the environmental impact on genes and possible epigenetic changes in a 
transgenerational approach. Therefore, we tested if CMS-induced behavioral 
changes can be transmitted in both males and females until generation F2. A 
potential transgenerational inheritance could be shown in the group where the 
parental generation, but not generation F1 and F2, was stressed (CMS-Co-Co). 
Particularly in female mice, a pronounced anxiogenic, but no pro-depressive effect of 
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CMS treatment, was observed in each generation (F1, F2). Interestingly, basal 
plasma corticosterone, a hormone involved in stress response, was significantly 
reduced for the CMS-Co-Co group in the male F2 generation, suggesting an affected 
basal neuroendocrine regulation over generations. Earlier studies discovered 
corticotropin-releasing hormone receptor 1 (Crhr1) as a plasticity gene in the 
environmentally manipulated HAB/LAB mouse model. In the basolateral amygdala, 
the expression of Crhr1, Cnksr2 (the candidate gene of environmental plasticity 
described here), as well as other genes associated with the HPA axis in male mice, 
were correlated with their behavioral performance in the light-dark box (LD) test. A 
negative correlation between anxiety and the expression of Crhr1 was detected in the 
CMS-Co-Co group. These findings are consistent with an at least partial 
transgenerational inheritance shown for the behavior in the LD test. Finally, to study 
possible mechanisms of EE-induced anxiolysis, we investigated adult neurogenesis 
in HAB mice after EE as well as memantine (MM) exposures. MM is a drug used to 
treat Alzheimer’s disease, a possible augmentation therapy of anxiety and known to 
increase neurogenesis in mice. In our study, both treatments, i.e. EE and MM, 
significantly decreased anxiety-related behavior of HAB mice and increased the 
number of newly born neurons. This shows that changes in anxiety-related behavior 
(environmentally- or pharmacologically-driven) appear to be closely associated with 
changes in hippocampal neurogenesis, whereas depression-like behavior seems to 
be unaffected. Taken together, effects of environmental manipulations could be 
detected in this study on the behavioral, structural and genetic level. The analysis of 
epigenetic mechanisms in the candidate genes from the microarray analysis, 
triggered by beneficial or adverse environmental manipulation, as well as of 
transmitted epigenetic states in the parents and offspring, might shed further light on 
how environmental effects can shape anxiety-related behavior in a long-lasting 
manner. Based on such findings, new and complementary treatment strategies have 
the potential to pave the way to escape from inborn predispositions or unfavorable 
epigenetically ‘fixed’ patterns. 
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1 Introduction 
1.1 Mental disorders – anxiety and depression disorders 
Mental disorders such as anxiety and depression impose an increasing burden on 
health worldwide and especially in western societies.  
These multifactorial disorders are described in two major classification systems – the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5, American Psychiatric 
Association, 2014) and the International Classification of Diseases (ICD-10, World 
Health Organization (WHO)). Anxiety disorders (e.g., generalized anxiety disorder 
(GAD)), neurodevelopmental disorders (e.g., intellectual disability), depressive 
disorders (e.g., major depressive disorder), trauma- and stressor related disorders 
(e.g., posttraumatic stress disorder (PTSD)), sleep-wake disorders (e.g., narcolepsy) 
or neurocognitive disorders (e.g., Alzheimer’s disorder) represent a small part of the 
about 300 psychiatric disorders listed and used for diagnosis of mental disorders in 
DSM-5 (2014). According to the WHO, at least 350 million people suffer from 
depression during their lifetime and almost one million people commit suicide every 
year as a consequence of their disorder (WHO, 2012). Depression as well as anxiety 
disorders have a two-fold higher lifetime prevalence in women than in men. These 
disorders also impact child development and growth since one to two out of ten 
mothers develop depression after childbirth (Kessler, 2003; Weissman and Olfson, 
1995). Moreover, as described in the WHO mental health action plan 2013-2020, 
mental disorders range from mental and behavioral disorders and have their onset 
already during childhood or adolescence (http://www.who.int/mental_health/ 
publications/action_plan/en/; 09.06.2015).  
Depressive and anxiety disorders show a great co-occurrence and very high 
comorbidity rates, which were detected in patients revealing specific vulnerability 
patterns (Kessler et al., 2008; Lamers et al., 2011). According to several studies, 
there is a 60% comorbidity of major depression and anxiety disorders (Landgraf, 
2001; Ressler and Nemeroff, 2000). For instance, a patient suffering from both panic 
disorder and social phobia has a 94% risk of developing depression (Simon and 
Fischmann, 2005; Stein and Uhde, 1988). Comorbidity should also be taken into 
account in the treatment of psychiatric disorders. In this study, both anxiety-related 
behavioral tests as well as depression-like tests were performed to detect changes at 
both anxiety and depression levels.  
Introduction 
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Non-pathological anxiety can be divided into two categories. State anxiety reflects 
acute anxious levels at a particular time, whereas trait anxiety is characterized as a 
long-term response and state (Clement et al., 2007; Gross and Hen, 2004; Sylvers et 
al., 2011). In contrast, pathological anxiety has a severe influence on life and is 
divided into six disorders (DSM-IV; Gross and Hen, 2004). 
This categorization changed in the new DSM-5, in which PTSD and obsessive-
compulsive disorders were separated and now form new categories. Specific phobia, 
social phobia, panic disorder, agoraphobia, separation anxiety disorder, selective 
mutism and GAD are now classified syndromes under anxiety disorders (American 
Psychiatric Association, 2014).  
Psychiatric disorders are complex, overlapping, and might be characterized as 
domains of disorder-related traits (Kas et al., 2007). It is notable that mental 
disorders such as anxiety and depression are polygenic (Plomin et al., 2009), in 
which many different variants are combined together with a small contribution 
(Sullivan et al., 2012). The biological mechanisms underlying psychiatric illness such 
as anxiety and depression are currently investigated with huge scientific effort, 
aiming to assemble the neurobiological basis of anxiety and depression step by step. 
 
1.2 Gene x environment interaction  
In the development of psychiatric disorders, besides genetic predisposition (see 
chapter 1.5), environment and epigenetics have been recognized as important 
factors for creating a phenotype. The interaction and correlation of genes with the 
environment contribute to the individual variation of anxiety and stress vulnerability 
up to the manifestation of psychopathology. Furthermore, in biological, social and 
medical sciences, environment has an increased relevance for brain function, 
behavior and physiology (Pryce et al., 2002).  
Several studies found various influences on symptoms of anxiety and depression in a 
gender- (Eaves et al., 1997; Heim et al., 2009) or age-specific manner (Tambs and 
Moum, 1993) and suggest that genes have an impact on environmental measures 
and vice versa (a relationship between individuals and their environment) (Kendler 
and Baker, 2007). A distinction between gene-environment interactions (GxE) and 
gene-environment correlation (rGE) is a crucial point to be considered in studies of 
gene and environment factors in psychiatric disorders (Nugent et al., 2011). rGE are 
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genetically conveyed dispositions to particular environmental events, whereas GxE 
are affected by an individual genetic response towards distinct environmental 
conditions (Lau and Eley, 2004; Plomin et al., 1977; Rutter and Silberg, 2002). Twin 
studies support the statement that even if a genetic predisposition exists, there is a 
considerable amount of population variance for developing different psychiatric 
disorders such as depression, anxiety or in cognitive development (Davis et al., 
2009; Landgraf, 2001). The high heritability of almost all psychiatric disorders as well 
as their accumulation in families was proven in several family, twin and adoption 
studies (Kendler, 2013).  
 
Research suggests that positive (beneficial) and negative (detrimental) environments 
can influence the interaction with genes, which show individual responsiveness to 
environmental stimuli (Belsky et al., 2009; Belsky and Pluess, 2009; Wolf et al., 
2008).  
Positive environment studies in animals were performed using the concept of 
enriched environment (EE), which can mimic positive life experiences in humans. 
The paradigm of EE arose from the “combination of inanimate and social 
stimulation”, which is reflected as “complex” environment (Rosenzweig et al., 1978). 
The main goal was to create a semi-natural environment with higher social 
interactions, exploratory and motor behavior. EE comprised an enlarged home cage 
with different biological stimuli for exploring, climbing and hiding opportunities as well 
as a grouped housing and additional nesting material. More and more studies are 
conducted to investigate influences of EE on different circuitries (Nithianantharajah 
and Hannan, 2006). Enrichment can have effects on physiological and behavioral 
properties such as improved memory and learning abilities (Kempermann et al., 
1997; Tang et al., 2001) or increased sensory (visual) capabilities (Sale et al., 2004). 
A growing body of data support the view “that early developmental mechanisms can 
set the lifelong tendency of an organism to express anxiety in response to 
threatening stimuli” (reviewed in Gross and Hen, 2004). During early development, 
several brain structures and neural circuits associated with anxiety show the highest 
plasticity such as the prefrontal cortex (PFC), amygdala and hippocampus (Gross 
and Hen, 2004). Moreover, it is well known that the beneficial EE induces anxiolytic 
effects, although the molecular mechanisms are not completely understood. A study 
found that downregulation of corticotropin-releasing hormone receptor 1 (Crhr1) 
Introduction 
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mRNA expression in the basolateral amygdala (BLA) (Kühne et al., 2012; Van Pett et 
al., 2000), a major region involved in anxiety regulation (Davis, 1992), was correlated 
with the anxiolytic effect of EE (Sztainberg et al., 2010). Crhr1 was critically 
implicated in high anxious mice exposed to EE and a decreased expression in the 
BLA and the central amygdala (CeA) was observed (Sotnikov et al., 2014b). In 
another study, not only the shift in a beneficial manner, but also adverse effects, 
regulated Crhr1 expression in the amygdala (Sotnikov et al., 2014a). Additionally, EE 
was associated with increased progenitor proliferation and differentiation in the 
amygdala, which can be involved in the beneficial anxiolytic aspects. In that study, 
EE increased bromodeoxyuridine (BrdU)-positive (BrdU+) newborn cells and 
suppressed cell death in the amygdala (Okuda et al., 2009).  
Besides amygdala, several different studies demonstrated that the hippocampus, 
which shows high plasticity, is susceptible to environmental stimuli. The hippocampal 
neurogenesis is increased in animals exposed to EE (Hosseiny et al., 2014; 
Kempermann et al., 1997). Moreover, there is growing evidence that neurogenesis is 
contributing to anxiolytic effects (Revest et al., 2009).  
Furthermore, research revealed that stress in early life is specified as moderate-
severe misery suffering during childhood or adolescence (Nugent et al., 2011). Early 
life stress (ELS) as a triggering factor might, in combination with genetic 
predisposition, lead to psychopathology (Nugent et al., 2011). EE can trigger 
changes in neural circuitry in the hypothalamus, which in turn can influence the 
hypothalamus-pituitary-adrenal (HPA) axis activity (Cao et al., 2010). Another 
important fact of EE has to be mentioned. EE has the potential to reverse negative 
consequences of ELS (Francis et al., 2002) as well as emotional disturbances in 
rodent models for schizophrenia, depression and PTSD (Takuma et al., 2011). These 
findings indicate that stress and the HPA axis play critical roles in changes caused by 
environmental influences during early life.  
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1.3 Hypothalamus-pituitary-adrenal (HPA) axis 
The HPA axis, together with another neuroendocrine system, the sympathetic-
adreno-medullary (SAM) system, regulates the function of the homeostatic balance in 
the body. Homeostasis is a complex dynamic equilibrium, which is permanently 
influenced and disturbed by intrinsic and/or extrinsic physical and physiological 
events, denoted as stressors (Charmandari et al., 2005; Chrousos and Gold, 1992). 
The term ‘stressor’ is defined as a ‘stimulus that threatens homoeostasis’ followed by 
the ‘stress response’, which is responsible to get the organism back to homeostasis 
(Chrousos, 2009). Koolhaas and colleagues emphasized that “stress should be 
considered as a cognitive perception of uncontrollability and/or unpredictability that is 
expressed in a physiological and behavioral response” (Koolhaas et al., 2011). 
Primarily, the hypothalamus responds to a stressor by activating the production and 
release of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) to 
hypophysial portal vessels synthesized by parvocellular neurons of the 
paraventricular nucleus of the hypothalamus (PVN). CRH, the main hypothalamic 
regulator, in turn promotes the secretion of adrenocorticotropin hormone (ACTH) 
from the anterior pituitary to systemic circulation by binding to its receptor on pituitary 
corticotropes. This is synergistically supported by AVP. Moreover, released ACTH 
travels in the bloodstream to the adrenal gland lying atop the kidney, where it 
stimulates the synthesis and release of glucocorticoid hormones from the zona 
fasciculata. In humans, cortisol is the most prominent glucocorticoid, whereas in 
rodents corticosterone (CORT) is the most prominent one (Melmed et al., 2011). 
Glucocorticoids are separated into a binary receptor system: the mineralcorticoid 
receptor (MR), which is responsive to low glucocorticoid concentrations and the 
glucocorticoid receptor (GR), which responds mainly to stress. Subsequently, ACTH 
and CRH secretion is restricted by glucocorticoids mediating the negative feedback 
mechanisms, which takes place on the level of pituitary gland, PVN and 
hippocampus (Charmandari et al., 2005; Jones et al., 1977; Lightman and Conway-
Campbell, 2010; Smith and Vale, 2006; Walker et al., 2010; Watts, 2005) (Fig. 1.1). A 
dysfunction of the stress system, indicated by a “sustained hyperactivity and/or 
hypoactivity”, can cause “psychiatric, endocrine, and inflammatory disorders and/or 
susceptibility to such disorders” (Chrousos and Gold, 1992; Tichomirowa et al., 
2005).  
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Figure 1.1: Schematic illustration of different levels of the hypothalamus-pituitary-adrenal (HPA) 
axis. The hypothalamus responds to many inputs like circadian stimuli or physical stressors with a 
secretion of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) from the 
paraventricular nucleus (PVN) to systemic circulation. Thus, the anterior pituitary secretes 
adrenocorticotropin hormone (ACTH), which induces glucocorticoid release such as corticosterone 
(CORT) from the adrenal cortex. Subsequently, ACTH and CRH secretion is limited by glucocorticoids 
mediating the negative feedback mechanism. (Figure adapted from Lightman and Conway-Campbell, 
2010) 
 
 
CRH is one of the major mediators of the effects of stress on the HPA axis and is 
therefore critically involved in the pathophysiology of stress-related disorders such as 
depression and anxiety (de Kloet et al., 2005; Holsboer and Ising, 2008; Nemeroff et 
al., 1984; Refojo et al., 2005; Reul and Holsboer, 2002). It is a 41-amino acid peptide 
with a 196-amino acid precursor and is widely expressed in the brain. Its biological 
action is mediated by two G-protein-coupled receptors, CRH-receptor 1 (CRHR1) 
and CRH-receptor 2 (CRHR2), which are distributed in neocortical, limbic and 
brainstem regions of the central nervous system (CNS) and on the pituitary 
corticotropes (Dautzenberg and Hauger, 2002) (reviewed in van Pett et al., 2000). 
Moreover, twin studies identified a high heritability of HPA axis components and a 
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high individual variation in its activity, which shows a strongly driven genetic 
background and environmental influence on the stress system (Mormede et al., 
2002; Mormede et al., 2011; Wust et al., 2004). A dysregulation of the HPA axis, for 
example genetic disturbance of MRs in adult mice, can affect neurogenesis in the 
hippocampus (Gass et al., 2000).  
 
1.4 Animal models – the HAB/LAB mouse model  
As psychiatric disorders are highly heritable and the number of patients keeps 
growing constantly, it becomes increasingly important to study the mechanisms 
behind these disorders. Both, genetic and environmental influences have to be taken 
into account. The study of GxE in humans shows limitation in monitoring 
environmental factors and risks, as well as the difficulty of controlling these factors 
(Heath et al., 2002). Therefore, animal models are the perfect study objects to 
investigate genes, environments and their interactions on multifactorial disorders 
(Kas et al., 2007). These models should share endophenotypes, which show 
behavioral, physiological, neuroendocrine and genetic characteristic symptoms 
analog to human psychopathology (Bakshi, 2002; Landgraf and Wigger, 2003). It is 
described that endophenotypes on the one hand represent an instrument to 
determine the ‘downstream’ traits or aspects of clinical phenotypes, and the 
‘upstream’ impacts of genes on the other hand (Gottesman and Gould, 2003). For 
research purposes, three endophenotypic criteria have to be fulfilled by an animal 
model to count as valid for the respective psychiatric disease. The first one, face 
validity, describes the similar symptomatology between the model and the human 
phenotype of the disorder. Similarities in underlying mechanisms and processes of 
the disorder refer to construct validity, whereas predictive validity has to enable 
potential therapeutic value for human psychopathology (Landgraf and Wigger, 2003). 
In addition, 87% alignment of all human gene-coding areas to mouse and rat (Brudno 
et al., 2004), identical biological pathways (blood pressure, feeding, etc.), and high 
sensitivity to environmental stimuli, makes rodents as perfect models (Kas et al., 
2007; Tecott, 2003).  
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In this study, an anxiety mouse model was used. Its breeding strategy was 
successfully applied in the 1980s, where Wistar rats were selectively bred for anxiety-
related behavior (Landgraf et al., 2007; Landgraf and Wigger, 2002; Liebsch et al., 
1998). Rats are potent model organisms for studying trait anxiety and comorbid 
depression on the behavioral and neuroendocrine level, but genetic methods are 
limited. Therefore, this selective breeding approach was applied using outbred Swiss 
CD-1 mice (Krömer et al., 2005). Two lines were bred for two extremes of anxiety-
related behavior: high anxiety-related behavior (HAB) and low anxiety-related 
behavior (LAB) mice. The key selection criterion was their behavioral performance on 
the well-established elevated plus-maze (EPM) test for testing anxiety-related 
behavior (Pellow et al., 1985). In this test, HAB mice were more anxious than LAB 
mice, independent of gender. The characteristic behavior in HAB mice is that they 
spend less than 10% of the total test time on the open arms of the EPM test, 
whereas LAB mice spend more than 50%. In addition, normal anxiety-related 
behavior (NAB) mice were bred showing intermediate ‘normal’ behavior on the EPM 
test. All three breeding lines are depicted in Fig. 1.2 with about 50 generations.  
 
 
Figure 1.2: Breeding course of high (HAB), normal (NAB) and low (LAB) anxiety-related 
behavior mice. The key selection criterion for breeding is the time spent on the open arms of the 
elevated plus-maze (EPM) test. 
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In this validated mouse model of pathological anxiety, several studies in all kinds of 
directions were conducted to reveal the underlying mechanisms of anxiety and 
comorbid depression. Starting on the behavioral level, HAB/LAB mice show a 
constant highly significant difference in their anxiety-related and depression-like 
behavior in the open-field (OF) test, light-dark box (LD) test, tail-suspension test 
(TST), forced swim test (FST) (Krömer et al., 2005) or predator odor avoidance 
(Sotnikov et al., 2011). Independent of the test, HAB mice showed higher measures 
of anxiety and depression. Further, a higher ultrasonic vocalization was detected in 
HAB compared to LAB mice (Krömer et al., 2005). Moreover, a higher level of activity 
and higher locomotor activity was revealed in male and female LAB mice than in 
HAB and NAB mice in other studies (Krömer et al., 2005; Landgraf et al., 2007). As 
LAB mice show hyperactivity, active coping styles and additionally cognitive 
dysfunctions, this mouse line was suggested to be a new model of attention deficit 
hyperactivity disorder (ADHD)-like symptoms (Yen et al., 2013). On proteomic level, 
combined with genetics, biomarker candidates were found, which are likely part of 
metabolic pathways crucial for the phenotype, especially for diseases (Ditzen et al., 
2010). Effects of single nucleotide polymorphisms (SNPs) (Kessler et al., 2007) or 
copy number variants (Brenndörfer et al., 2015) were also investigated in the mouse 
model for trait anxiety and depression. Genetic differences between HAB and LAB 
mice are described in chapter 1.5. 
Taken together, the results of studies in the HAB/LAB mouse model reveal this 
animal model as a valid model of anxiety-related and depression-like phenotypes. 
Based on this evidence, more possible neural and plasticity processes or genetic and 
epigenetic analyses can be studied to probably optimize future pharmaceutical 
therapies.  
 
1.5 Candidate genes 
As psychiatric disorders are known to be polygenic, the necessity of genome-wide 
association studies (GWAS) or/and whole transcriptome analysis to detect new risk 
candidate genes is increasing (Craddock et al., 2008; Czibere et al., 2011). 
Moreover, as neurobiological pathways are affected by multiple genes, a given gene 
has merely a small contribution to the variance in the risk for complex disorders 
(Nugent et al., 2011). As described in Belsky et al. (2009) a ‘framework of differential 
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susceptibility’ is suggested in which individuals change their ‘biological sensitivity to 
context’ (Boyce and Ellis, 2005). A possible candidate gene should have a conserved 
gene function across related species with a shared correlation between genotype 
and phenotype (Bunck et al., 2009; Kas et al., 2007). In the studies of GxE, 
interesting candidate genes, which respond to environmental manipulations are 
proposed to be ‘plasticity genes’ rather than ‘vulnerability genes’ or ‘risk alleles’ 
(Belsky et al., 2009). Anxiety disorders are lying at one end of a scale of anxiety 
continuum, whereas the opposite end would represent a state with extremely low 
anxiety. Individual states vary throughout their lifetime along this scale with very 
blurred boarders of what is pathological and what is not. Along this continuum, even 
rigid genetic predispositions to high anxiety can be shifted to a more intermediate 
level using epigenetic effects and environmental modifications. Genes related to 
these shifts react from both extremes on adverse factors like stress or beneficial 
stimuli in a ‘for better and for worse manner’ according to the ‘differential 
susceptibility hypothesis’ (‘plasticity hypothesis’) (Belsky et al., 2009; Belsky and 
Pluess, 2009; Pluess and Belsky, 2011). 
According to former studies and the well characterized HAB/LAB mouse model, 
several genes, SNPs and biomarkers were identified, which bear significant linkage 
to the observed phenotype in this model. To mention a few of them, glyoxalase-I was 
identified by microarray and proteomic analyses as a protein marker of trait anxiety in 
several brain regions, with a higher expression in LAB compared to HAB mice 
(Krömer et al., 2005; Landgraf et al., 2007). Additionally, the same phenotype-
dependent difference was found in the protein enolase phosphatase (Ditzen et al., 
2006; Ditzen et al., 2010). After quantitative real-time PCR confirmation, the 
microarray-based gene expression study by Czibere et al. (2011) identified 15 
differentially expressed candidate genes for the multigenic trait anxiety, e.g., high 
mobility group nucleosomal binding domain 3 (Hmgn3), cathepsin B (Ctsb),    
syntaxin 3 (Stx3). Among others, the neuropeptide Avp displayed a deficit, which is 
likely to contribute to the low anxiety of LAB mice. After central release, Avp plays a 
critical role in the regulation of anxiety-related and depression-like behavior and acts 
as an antidiuretic hormone after peripheral secretion (Bunck et al., 2009; Landgraf et 
al., 2007). Another candidate gene is the transmembrane protein 132d (Tmem132d). 
In the anxiety mouse model, a higher expression in HAB compared to LAB mice was 
observed, which was confirmed in human studies. Here, patients with risk genotypes 
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for panic disorder had higher Tmem132d mRNA expression levels in the PFC 
(Erhardt et al., 2011).  
Thus, genetic risk factors (e.g., SNPs) can accumulate over generations to place an 
individual along the anxiety continuum. In contrast and complementarily, there are 
epigenetic mechanisms, which allow the individual to adjust along this continuum 
during its life and even give the option to incorporate ‘freshly’ acquired traits.  
 
1.6 Transgenerational transmission 
Environmental factors can affect gene expression and lead to disease. Moreover, 
transgenerational implications a novel kind of non-genetic inheritance is a topic of 
increasing importance in disease etiology (Skinner et al., 2010). In the last years, a 
growing body of literature proposed that for phenotypic variation in complex traits 
transgenerational epigenetic effects are strong contributors, but the findings remain 
controversial (Arai et al., 2009; Heard and Martienssen, 2014; Skinner et al., 2010). 
Epigenetic transgenerational inheritance has been established in a variety of different 
species, ranging from plants to humans (Pembrey et al., 2014). As a first study, 
environmental factors like poisonous and harmful substances mediated 
transgenerational effects on reproductive disease (Anway et al., 2005) and nutritional 
abnormalities (high fat diet) (Dunn and Bale, 2011). Transgenerational effects of 
maternal care, ELS and exposure to stress are also described in several studies 
(Champagne and Meaney, 2007; Dietz et al., 2011; Gapp et al., 2014; Ward et al., 
2013). Epigenetic transgenerational inheritance refers to “the germline (egg or 
sperm) transmission of epigenetic information between generations in the absence of 
any environmental exposure” (Skinner, 2011; Skinner, 2014). These effects are 
independent of inherited changes in the primary DNA sequence (Daxinger and 
Whitelaw, 2012). In this case, a distinction between ‘intergenerational’ (parental) or 
multigenerational exposure and ‘truly transgenerational’ effects has to be made. The 
former refers to environmental factors such as hormonal factors, nutritional factors, or 
stress/toxins, influencing the embryo and its germline in utero. By contrast, 
generations not directly exposed to the triggering event are called true 
transgenerational effects. Phenotypes can be transmitted for two generations (F2 
generation) either through the parental lineage or through the maternal lineage. In 
the latter case, to establish transgenerational inheritance, the F0 female has to be 
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pregnant during exposure, which means the in utero (F1) as well as the germline of 
the fetus (the future F2) are affected. Therefore, phenotypic transmission for three 
generations (F3) is required. In conclusion, a transgenerational effect is considered 
when the germline is responsible for transmitting epigenetic information to the 
following generation (reviewed in Skinner, 2014; Stegemann and Buchner, 2015; 
Heard and Martienssen, 2014) (Fig. 1.3). The mechanisms behind the transfer 
across generations are epigenetically driven and not mediated by changes in DNA. 
 
Epigenetics is described as “molecular factors and processes around DNA that are 
mitotically stable and regulate genome activity independent of DNA” (Skinner, 2011; 
Skinner et al., 2010). DNA methylation, histone modifications, chromatin structure, 
and non-coding RNA are counted to epigenetic processes and result in a change of 
gene expression. DNA methylation is the most likely factor in germline transmission 
(Skinner, 2014), but all others play critical roles in regulating development (Berger et 
al., 2009; Rissman and Adli, 2014). Thus, this field of research is relatively new and 
future studies will be necessary to further evaluate the effects of transgenerational 
transmission and processes influencing the development of diseases.  
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Figure 1.3: Transgenerational and intergenerational effects. Environment (toxins, nutrition and 
stress) can induce epigenetic changes in mammals. To establish transgenerational inheritance 
through the maternal lineage, exposure on a pregnant female mouse can have an effect on the fetus 
in utero (F1) as well as the germline of the fetus (the future F2). This leads to intergenerational 
epigenetic inheritance, whereas only F3 individuals can be considered as true transgenerational 
inheritance. In the case of transmission through the paternal lineage, F0 and its germline (future F1) 
are exposed (intergenerational). Thus, F2 and following generations are taken as transgenerational 
inheritance. (Figure adopted from Heard and Martienssen, 2014).  
 
1.7 Neurogenesis in psychiatric disorders 
During the last years, scientists all over the world have been trying to reveal the 
mechanisms and the molecular and cellular basis of heterogeneous, multifactorial 
disorders like anxiety and depression. Neuroimaging studies showed that several 
brain regions related with stress, cognition, mood and emotion are altered in patients 
with mood disorders, displaying abnormalities in structure and function (Drevets et 
al., 2008; Phillips et al., 2003). An interesting circuit involved in these processes is 
the limbic-cortical-striatal-pallidal-thalamic circuit. In this, orbital and medial prefrontal 
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cortex, amygdala, hippocampal subiculum, ventromedial striatum, mediodorsal, 
midline thalamic nuclei and ventral pallidum are connected (Ongür et al., 2003). 
Besides genetic studies in these brain areas and the importance of amygdala in 
anxiety disorders, a focus on the well-studied hippocampus in depression gained 
raising interest. The hippocampus is a brain region, which is connected to the 
amygdala and PFC (Duman and Monteggia, 2006). It is known to impact on the 
pathogenesis of depressive disorders, is involved in learning and memory (Jarrard, 
1993) and is highly stress sensitive (Lupien et al., 2009). Thus, another important 
factor in dysfunction of brain regions and neuronal circuits is the regulation of adult 
neurogenesis (reviewed in Zhao et al., 2008). The neurogenesis is altered during 
stress, acutely or chronically, which leads to adaptive changes in the hippocampus 
(Warner-Schmidt and Duman, 2006). In the development of the brain and its 
functioning, appropriate types of neurons are necessary to be generated in the 
correct numbers and places, to migrate to their final positions and to set up synaptic 
connections (Abrous et al., 2005). Neurogenesis is the proliferation and 
differentiation of adult neural stem cells or progenitors, which is known to continue 
during adulthood throughout life. Newly born cell proliferation and survival occurs in 
two specific brain areas: the subventricular zone (SVZ) and the subgranular zone 
(SGZ). SVZ forms the lining of the lateral ventricles, in which the neurogenic process 
proceeds in the olfactory bulb (OB), and the SGZ forms part of the dentate gyrus 
(DG) of the hippocampus area. In the OB, the newborn olfactory neurons mature, 
differentiate mostly into interneurons, functionally integrate into preexisting neural 
networks and form synaptic connections, whereas in adult SGZ born neurons 
become dentate granule cells (Abrous et al., 2005; Braun and Jessberger, 2014; 
Zhao et al., 2008). In the SGZ, two different types of neural progenitors are specified, 
which differ in their distinct morphologies and their molecular markers expression 
(Fig. 1.4). Type 1 cells grow in a radial process through granular cell layer (GCL) into 
molecular layer (Mol). These radial glia-like neural stem cells can in turn be activated 
for generating proliferation and transiently amplifying type 2 non-radial cells. This 
then can cause proliferation of neuroblasts and postmitotic immature neurons 
(reviewed in Christian et al., 2014). Finally, the neurons mature into DG granular cells 
over a period of three weeks. When they are incorporated into the circuitry, less than 
25% of the newborn neurons survived. These granular neurons are functionally and 
synaptically integrated and can form synaptic connections for receiving inputs such 
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as depolarizing responses to GABA or sending synaptic outputs in terms of 
glutamate (reviewed in Christian et al., 2014). 
 
 
Figure 1.4: Neurogenesis in the dentate gyrus of the hippocampus. In the subgranular zone,    
type 1 and type 2 progenitor cells can be distinguished by their distinct morphologies and their 
molecular markers expression. Newborn neurons develop through a number of different stages, 
whereby, a transition from GABA (blue) excitatory to GABA inhibitory and glutamate excitatory inputs 
arise during the third week after cell birth. GCL, granule cell layer; Mol, molecular layer. (Figure 
adopted from Zhao et al., 2008). 
 
As already mentioned above, stress is a particularly adverse factor in the regulation 
of progenitor proliferation and new-neuron survival. Rising evidence indicates that 
adult hippocampal neurogenesis plays a discriminating role in the suppression of the 
HPA axis in stress response (Christian et al., 2014). This phenomenon appears in 
stressed animals and in human patients suffering from major depression (Zhao et al., 
2008). Numerous studies reported a reduction of cell proliferation in the SGZ caused 
by chronic stress (Mirescu and Gould, 2006). 
Thus, the DG is a dynamic structure. Dysfunctions in this developing system of adult 
hippocampal neurogenesis can exist in several brain disorders, which is investigated 
in animal model studies. Future studies have to focus on various different dynamic 
up- and down-regulated factors such as endocrine, environmental and 
pharmacological ones. 
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1.8 Treatment of psychiatric disorders 
Over the past years, treatment of psychiatric disorders started with treating 
symptoms of each disorder separately. Due to the comorbidity of anxiety and 
depression, more and more antidepressants have to act on several levels and have 
to influence multiple networks. A main goal for the development of effective 
pharmaceutical and/or psychological therapies has to be a reduction of side effects. 
Research has elucidated that a combination of different treatments including 
behavioral therapy are most effective. Around 50% of patients suffering from anxiety 
disorders only respond partly to a chosen pharmacotherapy and need augmentation 
therapy (Ballenger, 1999; Schwartz et al., 2005). Several different classes of 
antidepressants, including serotonin reuptake inhibitors (SSRIs), serotonin-
norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs) and 
monoamine oxidase inhibitors, are well-established. Anxiolytics such as 
benzodiazepines (BZ), a SSRI class, are the most widely used pharmaceutical 
treatments, acting on GABA and function acutely on anxiety (Macaluso et al., 2010). 
By contrast, most of the available treatments need weeks or months to show a 
response in patients. As BZs are most effective the first six weeks, a high relapse 
rate occurs, when a discontinuation is applied. Therefore, a chronic treatment and 
additional therapies are widely used for an appropriate treatment (reviewed in 
Ballenger, 1999). 
Adult neurogenesis can also be altered by treatment against depression. Several 
studies revealed that antidepressant drugs increase adult neurogenesis in the DG in 
contrast to stress, which is reducing cell proliferation (Mirescu and Gould, 2006; 
Warner-Schmidt and Duman, 2006). This decreasing effect can be reversed or 
hindered by antidepressants such as fluoxetine, a serotonin-selective reuptake 
inhibitor. Chronic administration of fluoxetine enhances proliferation and survival of 
newborn neurons (Encinas et al., 2006). Moreover, several co-regulations of SGZ 
neurogenesis by antidepressants are existent and under current investigations. For 
example, the brain-derived neurotrophic factor shows increasing effects on 
neurogenesis in the survival of newborn neurons as well as anti-depressive effects 
on behavior in presence or absence of antidepressants (Duman and Monteggia, 
2006). Moreover, the administration of insulin-like growth factor 1 is described to 
increase neurogenesis and cause effects on depression-like and anxiolytic behaviors 
(Duman and Monteggia, 2006; Malberg et al., 2007).  
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Furthermore, several trials suggest augmentation therapy as a common use for 
treating psychiatric disorders if conventional antidepressant anxiolytics fail (Schwartz 
et al., 2005). New findings in patients propose memantine (MM) as a drug effective 
for generalized or social anxiety disorders (Schwartz et al., 2012), for depression, 
ADHD or dementia disorders such as Alzheimer’s disease (reviewed in Thomas and 
Grossberg, 2009). This drug was described to be a possible therapeutic treatment for 
augmentation therapy of anxiety disorders. MM is a noncompetitive N-methyl-D-
aspartate (NMDA) glutamate receptor antagonist and a well-tolerated drug for 
treatment of Alzheimer’s disease (Bassil and Grossberg, 2009). It plays a role in the 
glutamate-GABA balance, creating less “side effects (weight gain, sexual problems, 
(e.g., SSRI/SNRI), or addiction (e.g., sedatives))” (Schwartz et al., 2012). Recently, it 
has been shown to increase neurogenesis in mice (Akers et al., 2014). The rising 
numbers of patients suffering from anxiety and depression imply to a huge task for 
future research to develop novel antidepressants agents. 
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1.9 Aims of the thesis 
The focus of this thesis was the impact of gene x environment interactions (GxE) on 
different levels of anxiety-related and depression-like behavior. We took advantage of 
the extreme genetic predisposition of inborn anxiety of the HAB/LAB mouse model 
and used two different approaches of early life environmental modifications to induce 
a bidirectional shift towards ‘normal anxiety’ – a more beneficial (EE) and an adverse 
one (CMS).  
1. To investigate novel candidate genes, which are differentially expressed 
between the mouse lines while exposed to diverse environmental conditions, 
we performed a microarray-based basal gene expression profiling, covering 
the whole genome. This investigation was performed in the BLA of HAB, LAB, 
HAB-EE and LAB-CMS animals, a brain area known to be involved in anxiety 
and depression pathogenesis. Potential plasticity genes were validated via 
qPCR analysis to verify the involvement in environmental manipulations in the 
anxiety mouse model. 
2. Another important question examined in this work was if anxiogenic effects of 
adverse environmental experiences in one generation may profoundly impact 
behavior of subsequent generations. To assess whether transgenerational 
transmission of CMS-induced behavioral changes occur in both males and 
females, we analyzed all offspring up to generation F2 in a behavioral test 
battery. Additionally, basal CORT was measured in generation F2 to evaluate 
the basal HPA axis activity likely to be related to anxiety.  
3. Based on previous studies by Sotnikov et al. (2014), Crhr1 was found to be 
involved in trait anxiety and showed plasticity in the bidirectional manipulations 
in the BLA. Therefore, the expression of Crhr1 and further candidate genes 
were measured in the CMS transgenerational transmission approach to reveal 
behavioral and expression correlations over generations. 
4. To establish a further link between anxiety predisposition and behavioral shifts 
on anxiety-related/depression-like behavior, we included a pharmacological 
approach to influence neurogenesis. Therefore, the effect of beneficial 
environmental modification (EE) and memantine (MM) as proneurogenic 
treatment was investigated. 
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2 Materials and Methods 
2.1 Animals 
HAB and LAB mice used in the following studies originated from generations 45 – 53 
and were bred in the animal facility of the Max Planck Institute of Psychiatry in 
Munich. All animals were kept under standard housing conditions (room temperature 
23 ± 2°C, relative air humidity 60 ± 5%, 12:12 h light/dark cycle with lights on at         
8 a.m.), with pelleted food (Altromin 1314 TPF; protein 22.5%, fat 5%, fiber 4.5%,  
ash 6%, Altromin GmbH, Lage, Germany) and drinking water ad libitum.  
Before any behavioral testing, a five days habituation phase was provided after 
transferring the mice from their breeding facility to a room next to the testing room. 
For both environmental manipulations, control groups were housed in Makrolon 
cages type II (207 x 140 x 265 mm; Bayer MaterialScience, Leverkusen, Germany) 
including bedding and nesting material (LIE E-001, Abedd Lab and VET Service, 
Vienna, Austria) either in groups of three (HAB) or single (LAB) of the same sex 
without any manipulations, except a weekly cage change. The animals used for EE 
were group-housed (three or up to four) in Makrolon cages type IV                        
(380 x 200 x 590 mm), and the mice used for CMS treatment were kept single-
housed in Makrolon cages type II. For the transgenerational approach male and 
female mice were taken for breeding in Makrolon cages type III (265 x 150 x         
420 mm), for the neurogenesis experiment female mice were used only, otherwise all 
molecular experiments were carried out with male mice.  
All animal experiments were carried out according to current regulations for animal 
experimentation in Germany and Austria and the European Union (European 
Communities Council Directive 86/609/EEC). The presented work was announced 
and approved by the appropriate local authority.  
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2.2 Behavioral testing for assessing anxiety-related and depression-like 
behavior 
All behavioral tests were performed during the light phase between 09:00 a.m. and 
01:00 p.m. to assure equally low basal CORT levels due to the circadian rhythm. 
Evidence was found that circadian rhythms are disturbed and dysregulated in HAB 
mice, a mouse model for anxiety and comorbid depression (Griesauer et al., 2014). 
For assessment of anxiety-related behavior, we performed different well-established 
tests utilizing approach-avoidance conflicts (Bailey and Crawley, 2009; Bourin and 
Hascoet, 2003; Cryan and Holmes, 2005). 
In order to test depression-like behavior in mice, the animals were exposed to a 
desperate, uncontrollable situation where they were not able to escape or extricate 
themselves, and their behavior was assessed (Cryan and Holmes, 2005). As a 
natural strategy the mice have to cope with the situation actively or passively 
(depression-like) (Lino-de-Oliveira et al., 2002). Two different behavioral reactions 
can be distinguished, the ‘active’ characterized as an active attempt to escape from 
the situation and ‘passive coping strategy’ in which the situation seems to be 
accepted (Krömer et al., 2005).  
 
2.2.1 Open field (OF) test 
The OF test was used to assess locomotor activity and explorative behavior (Prut 
and Belzung, 2003). We applied a setting with moderate illumination to measure 
anxiety-related behavior (Walsh and Cummins, 1976). The apparatus consisted of a 
grey circular open field PVC arena including a wall of 40 cm height and a field of     
60 cm in diameter (see Fig. 2.1). Two different zones were set comprising the inner 
central zone lit with <50 Lux to create an aversive area and the surrounding outer 
zone with 15 Lux as a less challenging part. At the beginning of every test session, 
the mouse was placed into the central inner zone. The OF test lasted 5 min and was 
videotaped using a computer software (Any-maze 4.50, Stoelting, Illinois, USA).  
Any-maze tracking software was used to analyze the animal’s behavior. The 
parameters assessed in this test were ‘total distance traveled’ and ‘percentage time 
spent in the inner zone’. After testing, the animal was returned to its home cage and 
the maze was cleaned with soapy water, 70% ethanol and dried to leave no odor 
cues for the subsequent animal. 
Materials and Methods 
 
21 
 
 
Figure 2.1: Open field (OF) test apparatus. The experimental setup of the OF test consisted of an 
open field arena surrounded by walls. 
 
2.2.2 Elevated plus-maze (EPM) test 
The EPM test, a plus-shaped platform, which was elevated 40 cm above the floor, is 
one of the common behavioral tests for anxiety-related behavior. With this 
experimental setup the behavior in aversive environment, like illuminated exposed 
areas as well as the natural exploratory behavior of mice, was analyzed (Lister, 
1987). It consisted of two opposing open arms (30 x 5 cm) representing an aversive 
environment and two opposing closed arms (30 x 5 x 15cm) on the sides reflecting a 
save environment connected by a central zone (Fig. 2.2). To set a conflict to either 
explore the new environment or to avoid the unprotected open arms (Pellow et al., 
1985), the open arms were lit by white light of 300 Lux or otherwise the closed were 
dimly lit with 10 Lux. At the beginning of every test session, the mouse was placed 
into the central zone of the plus-shape facing a closed arm. Different parameters 
were automatically measured by the Any-maze software (Any-maze 4.50, Stoelting): 
time spent on the open arms, the percentage time spent on the open arms (ratio of 
time spent on the open arms to (total test time – time spent in the neutral zone) in 
percent), the number of open arm entries, latency to the first open arm entry and the 
total distance traveled for assessing explorative behavior were videotaped for 5 min 
and analyzed using the Any-maze software. The apparatus was cleaned with 
detergent containing water and 70% ethanol before each test to avoid odor irritation. 
 
Materials and Methods 
22 
 
 
Figure 2.2: Elevated plus-maze (EPM) test. The experimental setup of the EPM test consisted of two 
opposing brightly lit open arms and two opposing dimly lit closed arms. 
 
2.2.3 Light-dark box (LD) test 
The LD test was composed of two chambers, a light compartment (32 x 27 x 27 cm) 
and a dark compartment (16 x 27 x 27 cm) illuminated with 300 Lux and <20 Lux, 
respectively. The compartments were divided by a wall with a connecting opening   
(5 x 5 cm) at floor level (Fig. 2.3). The clear separation in light exposure of the two 
chambers was to create a protected and an aversive environment (Bourin and 
Hascoet, 2003). To assign anxiety-related behavior, percentage time spent in the 
light compartment, number of entries and latency to the first entry to the light 
compartment were measured during 5-min testing. A mouse showing anxious 
behavior spent significantly more time in the dark, protected compartment than mice 
treated with anxiolytic drugs (Costall et al., 1989). Each test session started with the 
mice placed into the dark compartment, and after every mouse the apparatus was 
cleaned with water containing detergent and 70% ethanol. The test was videotaped 
by Any-maze software (4.50, Stoelting) and analyzed by a trained person blind to line 
and treatment using Eventlog 1.0 software (EMCO Software, Reykjavik, Iceland). 
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Figure 2.3: Light-dark box (LD) test. Experimental setup of the LD test consisted of a light and a dark 
compartment. 
 
2.2.4 Tail-suspension test (TST) 
The TST apparatus was a metal frame on which the mouse was suspended with the 
last 2 cm of its tail by an adhesive tape (Fig. 2.4). Four mice were tested 
simultaneously and were recorded with a video camera for 6 min. The videos were 
later analyzed by a trained person blind to line and treatment using the computer-
based Eventlog program (1.0, EMCO Software). This test was used to assess 
depression-like behavior (Cryan and Mombereau, 2004; Steru et al., 1985), and two 
different coping styles were distinguished. Moving of mice was defined as active 
coping (Fig. 2.4 A), whereas immobile phases counted as passive coping             
(Fig. 2.4 B). Immobility was considered when animals stopped any body movements, 
except minor head swinging, which was used as an indicator for depression-like 
behavior. 
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Figure 2.4: Tail suspension test (TST). Experimental setup of the TST consisted of a metal frame on 
which the mice were suspended by their tail, showing (A) immobile or (B) moving behavior.  
 
2.2.5 Forced swim test (FST) 
As the second test for measuring depression-like behavior in a highly aversive and 
inescapable situation, we used the FST, in which the mouse was forced to swim 
(Porsolt et al., 1977). The FST is the primary and most commonly used test for 
screening antidepressants. This test creates an aversive situation, which is a strong 
physical and psychological stressor for the mice (Landgraf et al., 2007). During the  
6-min session, the mouse was placed into a 2 l glass cylinder, filled with tap water 
(room temperature 22.5 ± 1°C) to a level preventing the mouse from escaping the 
cylinder and touching the bottom with its tail (Fig. 2.5). The mouse was dried with a 
towel before placing it back into its home cage. Three types of behavior were 
observed in the FST. Struggling was taken as actively trying to escape the aversive 
situation with intense, intermittent vertical movement of the two forepaws, while a 
forward acting swimming movement of all four legs underneath the water surface was 
counted as swimming. If the mouse was not showing any movement, except for slight 
balancing movements, it was defined as floating, which corresponds to behavioral 
despair (Porsolt et al., 1978). The behavior of the mouse was videotaped with a 
camera and later analyzed using the computer-based Eventlog 1.0 software    
(EMCO Software). Time spent, latency to first and total numbers of each respective 
phenotype were scored for statistical analysis.  
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Figure 2.5: Forced swim test (FST). Experimental setup of the FST consisted of a glas cylinder filled 
with water. 
 
2.3 Environmental manipulations 
 
The extreme genetically fixed predisposition of the anxiety-related behavior mouse 
model (HAB/LAB) was used as a basis for environmental manipulations in a 
beneficial (EE) or adverse (CMS) way to test, if the behavior can be changed towards 
‘normal’ behavior. Here, we wanted to reflect the hypothesis ‘for better and for worse 
manner’ (Belsky et al., 2009; Belsky and Pluess, 2009), in which both beneficial vs. 
adverse environmental manipulations have an impact on anxiety-related behavior. 
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2.3.1 Enriched Environment (EE) 
The EE design for HAB mice was adapted from Arai et al. (2009) and Sotnikov et al. 
(2014) and was used for increasing anxiolytic effects (Markt, 2012).  
The paradigm of EE is divided into partial and full enrichment, both lasting 14 days. 
Partial enrichment started at postnatal day (PND) 15 with a 6 h/day transfer of pups 
and their respective dam to EE. At PND 28, pups were weaned and transferred to EE 
permanently in groups of three to four until PND 42 (full enrichment) (Fig. 2.6). EE 
mice were kept in an enlarged home cage (Makrolon cage type IV) with different 
biologically relevant stimuli. These included additional nesting material and a             
6 ± 0.5 cm thick layer of wood chips (LIE E-001, Abedd Lab & VET Service), retreat 
options like a plastic inset (22 x 16 x 8 cm) and a tunnel (19.5 x 6 x 6 cm), as well as 
a wooden ladder and scaffold as climbing possibilities. At the weekly cage change, 
half of the nesting material was transferred to the new cage to prevent aggressive 
behavior with remaining olfactory marks (Olsson and Dahlborn, 2002).  
After the two weeks period of full enrichment, a behavioral test battery was 
performed to test the effect of EE. We tested in 48 h test intervals, starting with OF 
test, followed by EPM and LD tests (described in 2.2.1 – 2.2.3). The EE mice 
remained in a bigger cage with toys under standard housing conditions for the entire 
period of testing (see 2.1).  
 
 
Figure 2.6: Time course of enriched environment (EE) of HAB mice. Partial enrichment started at 
postnatal day (PND) 15 with 6 h per day in EE, and mice remained in full EE from PND 28 followed by 
a behavioral test battery including open field (OF), elevated plus-maze (EPM) and light-dark box (LD) 
tests.  
 
 
Materials and Methods 
 
27 
 
2.3.2 Chronic mild stress (CMS)  
In contrast of creating a beneficial environment in the EE paradigm, for the CMS 
design we used alternating mild stressors to initiate anxiogenic and pro-depressive 
effects in LAB mice. The CMS treatment lasted the same period of time as EE and 
was adapted from Willner et al. (1987) and Sotnikov (2013). The mild stressors 
included from PND 15 to 28 maternal separation (3 h per day; 7 days litterwise,         
7 days alone), restraint stress (PND 28 - 42, 30 min per day, see Fig. 2.7), light off 
during light phase (3 times for 5 h), overnight illumination (twice overnight), damp 
sawdust (twice overnight), cage tilting (3 times 45°C for 7 h), overcrowding (4 mice 
per Makrolon cage type II, twice overnight) or paired housing (once overnight), 
stroboscopic illumination (3 times for 7 h), mild footshock (once 0.7 mA with 2 s 
duration), white noise (85 dB 3 times for 3 h), damp sawdust (twice overnight), 
placement to an empty cage with water at the bottom (twice for 1 h) or just in an 
empty cage (3 times overnight). The stressors were distributed randomly over the 
four weeks to avoid adaptation, but included not more than two stressors per day. 
For ethical reasons, food and water deprivation were excluded. Like in EE, 
behavioral phenotyping was conducted according to the 48 h protocol as described 
above but without OF test, and for determination of depressive-like behavior, TST 
and FST followed.  
 
 
Figure 2.7: Time course of chronic mild stress (CMS) paradigm of LAB mice. This stressor 
paradigm lasting for four weeks, started at postnatal day (PND) 15 with maternal separation adding 
more stressors, and from PND 28 restraint stress plus one of several mild stressors was conducted. 
After the different stressors, a behavioral test battery including elevated plus-maze (EPM), light-dark 
box (LD) tests, tail-suspension test (TST) and forced swim test (FST) was conducted.  
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2.4 Transgenerational inheritance setup of LAB mice 
In this study, we tried to assess whether transgenerational transmission of CMS-
induced behavioral changes occur in both males and females. Therefore, we 
analyzed all offspring up to generation F2 in a behavioral test battery after every 
CMS manipulation.  
As described in 2.3.2, LAB mice were housed until PND 50 and were mated 
according to their respective behavior. Therefore, two test parameters of anxiety-
related behavior were considered: ‘% time spent on the open arms’ in the EPM test 
and ‘% time spent in the light compartment’ in the LD test. These two parameters 
served as the key measures of anxiety-related behavior from both tests, as they are 
least influenced by locomotor activity. Animals performing below and above the 
respective group means were taken for mating.  
For mating, animals were kept together for 14 days in Makrolon cages type III. After 
determining pregnancy, males and their respective females were separated, and all 
females with their offspring remained in the Makrolon cages type II until PND 15. 
After this time point, the chronic mild stress started for all CMS groups with maternal 
separation, followed by a set of different mild stressors (described in 2.3.2). All non-
stressed control (Co) mice were weaned at PND 29 and single-housed in Makrolon 
cages type II without any manipulation. Breeding was continued until F2. To 
phenotype each generation a behavioral test battery was used as described in      
Fig. 2.8 and 2.9. In addition, basal CORT levels were analyzed in F2 mice. Data 
acquired from males and females were examined separately. The nomenclature 
used to describe each generation and treatment is illustrated in Fig. 2.8. 
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Figure 2.8: Transgenerational breeding from parental (P) generation until F2 generation 
showing the possible transgenerational inheritance in LAB mice. All groups of generations are 
shown including their abbreviations. Co, control; CMS, chronic mild stress.  
 
Control (Co, Co-Co, Co-Co-Co): animals were always single-housed under standard 
conditions in Makrolon cages type II without any disturbance apart from a weekly 
change of cage. 
CMS-Control (CMS-Co): parental (P) generation was exposed to different stressors 
and offspring were raised as control mice. 
CMS-CMS-Control (CMS-CMS-Co): P and F1 generation received CMS and 
offspring were raised as control mice. 
CMS, CMS-CMS, CMS-CMS-CMS: all three generations underwent the CMS 
treatment. 
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Figure 2.9: Time course of the transgenerational setup of the chronic mild stress (CMS) 
paradigm of LAB mice. As described in 2.3.2, additionally, mating and treatment time of the next two 
generations are included. This stressor paradigm started at postnatal day (PND) 15 with maternal 
separation, and from PND 28 restraint stress plus one of several mild stressors was conducted. After 
the different stressors, a behavioral test battery including elevated plus-maze (EPM), light-dark box 
(LD) tests, tail-suspension test (TST) and forced swim test (FST) was conducted. 
 
2.5 HPA axis 
2.5.1 Basal corticosterone sampling 
For the possible transgenerational transmission of stress, we wanted to compare the 
basal CORT levels between the four groups (Co-Co-Co, CMS-Co-Co, CMS-CMS-Co, 
CMS-CMS-CMS) of males and females, respectively, in generation F2. HPA 
reactivity and feedback regulation was not tested, as FST, a strong stressor, was 
used as a test for assessing depression-like behavior. Thus, we did not want to apply 
a second strong stressor to all animals.  
Therefore, 24 h after the CMS treatment of F2 and before all behavioral tests were 
performed blood samples from animals between 09:00 a.m. and 11:30 a.m. were 
collected. Basal blood samples were collected from the ventral tail vessel within 
timeframes of no longer than 2 min in Microvette CB300 coated with potassium-
EDTA tubes (Sarstedt, Nümbrecht, Germany) and were centrifuged for 10 min at 
4000 rpm (4°C) to separate plasma and cellular components. The upper plasma 
phase was transferred into a clean 1.5 ml Safelock tube (Sarstedt) and stored at        
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-20°C for further analysis by radioimmunoassay. If the 2-min limit was exceeded, the 
basal stress level could not be ensured and thus, those results were excluded.  
 
2.5.2 Radioimmunoassay (RIA) 
Basal CORT concentration was measured using a commercial RIA kit (DRG 
Instruments GmbH, Marburg, Germany) by following the manufacturer’s protocol with 
slight modifications. Therefore, 10 µl of blood plasma were taken and diluted 1:13.5 
with the Kit Diluent. All samples were measured in duplicate, intra- and inter-assay 
coefficients were below 10%. For further calculations, mean values from double 
detections were taken and samples that deviated more than 10% were excluded from 
statistical analysis. To avoid intra-assay variations, pooled samples of the initial 
CORT concentration were run at the beginning and at the end of the assay. For 
calculation of the CORT concentration, a standard curve with known CORT 
concentrations was used. Radioactivity was measured in a gamma counter (Wallac 
Wizard 1470 automatic gamma counter, Perkin Elmer Life Science, Rodgau, 
Germany). 
 
2.6 Brain harvesting 
For brain harvesting, all mice were decapitated after Forene (Abbott GmbH, 
Wiesbaden, Germany) anesthesia under baseline conditions, and brains were 
carefully removed and quick-frozen in dry ice-cooled 2-methylbutan (Carl Roth 
GmbH, Karlsruhe, Germany). Brains were stored at -80°C until further use.  
 
2.7 Tissue dissection 
Frozen brains were embedded in tissue freezing medium (Jung, Nussloch, Germany) 
and sectioned in a cryostat (Microm MH50, Microm, Walldorf, Germany) from rostral 
to caudal. Slices were collected starting at the level of the corpus callosum (Bregma 
3.08 mm) until ventral hippocampus was unfolded (Bregma -3.08 mm). The 200 µm 
slices were fixed on Superfrost microscope slides (Menzel GmbH, Braunschweig, 
Germany) and were stored at -80°C until micropunching.  
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To assess gene expression, different target brain regions were determined according 
to the Mouse Brain Atlas 2nd edition (Paxinos and Franklin, 2001). For micropunching 
procedure (Palkovits, 1973), cingulate cortex (Cg), hypothalamic paraventricular 
nucleus (PVN) and basolateral amygdala (BLA) (see Fig. 2.10) were punched out 
with micropunchers with a diameter of 0.5 or 1.0 mm (Fine Science Tools GmbH, 
Heidelberg, Germany). Depending on the region, two to six punches were collected 
in 1.5 ml RNase free Safelock tubes (Eppendorf, Hamburg, Germany).  
 
 
Figure 2.10: Target brain regions acquired by micropunching. Red circles indicate the location of 
micropunched areas (A) cingulate cortex (Cg), (B) hypothalamic paraventricular nucleus (PVN) and 
(C) basolateral amygdala (BLA). (Figures adapted from Mouse Brain Atlas 2
nd
 edition, Paxinos and 
Franklin, 2001). 
 
 
 
 
Materials and Methods 
 
33 
 
2.8 Molecular methods 
2.8.1 Total RNA isolation 
All RNA-based methods were conducted under a fume hood, surfaces and 
equipment were treated with 70% ethanol followed by RNase Zap (Ambion, Austin, 
USA) before and after usage. For all steps, presterilized 1.5 ml Safelock tubes and 
RNase free filter tips (Sarstedt) were used to avoid RNA degradation by 
contamination with RNases.  
 
2.8.2 Isolation from BLA for microarray analysis 
Total RNA was isolated out of BLA micropunches for microarray analysis according 
to a TRIzol/Chloroform standard protocol. First, 300 µl pre-cooled (4°C) TRIzol/Tri 
Reagent (Sigma-Aldrich, Taufkirchen b. München, Germany) and 30 µl bidistilled 
water (Aqua ad iniectabilia, Braun, Melsungen, Germany) were added to each tube 
containing brain punches from one animal, and the tissue was briefly homogenized 
by up and down pipetting using a 200 µl pipette. After adding 1 µl linear acrylamide  
(5 mg/ml, Ambion) and 60 µl chloroform (Carl Roth GmbH), the samples were 
vortexed (Vortexer VF2, Janke & Kunkel GmbH, IKA®-Labortechnik, Staufen, 
Germany) for about 30 s and centrifuged for 5 min at 18°C and 13000 rpm 
(Centrifuge type Z216MK, Hermle Labortechnik GmbH, Wehingen, Germany). The 
centrifugation was necessary to separate the aqueous from the organic phase, and 
140 µl of the upper aqueous phase containing RNA were transferred into a clean   
1.5 ml Safelock tube. The inter- and lower organic phase were discarded. To 
precipitate RNA, 180 µl of pre-cooled isopropanol (Carl Roth GmbH) were added to 
the aqueous phase, and samples were incubated at -20°C overnight.  
On the next day, purification steps followed starting with centrifuging the samples for 
30 min at 4°C and 13000 rpm. The supernatant was removed and the samples were 
washed with 500 µl pre-cooled (4°C) 70% ethanol two times each with a following 
centrifugation step at 4°C and 13000 rpm for 10 min and discarding the supernatant. 
After the two washing steps, the samples were shortly centrifuged at full speed and 
remaining liquid was removed with a 20 µl pipette. The pellet was dried in a 
thermoshaker (Grant Instruments Ltd, Cambridgeshire, England) at 45-50°C for        
5 min with open lids without overdrying. In order to redissolve the pellet, 15 µl of 
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ddH2O were added by pipetting up and down 10 to 20 times. In a last procedual step, 
samples were briefly heated (1-2 min) to 95°C in the thermoshaker and spun down 
shortly at full speed. For the microarray, RNA quality and concentration were 
measured by using RNA NanoChips and the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Böblingen, Germany). To assess the RNA quality, the RNA integrity 
number (RIN factor) was measured and RIN factors >7.15 were taken as satisfactory 
results (Kiewe et al., 2009). Data was translated into gel-like images (bands) and 
electropherograms (peaks). All microarray probes were checked before and after 
amplification. The isolated RNA was stored at -80°C until further use.  
 
2.8.3 Isolation from brain tissue micropunches for other analysis 
For further qPCR studies (see 2.8.5), a combined RNA isolation from 
TRIzol/Chloroform protocol and RNeasy® Plus Micro Kit (Qiagen GmbH, Hilden, 
Germany) was used. Therefore, 500 µl pre-cooled (4°C) TRIzol/Tri Reagent were 
added to each micropunching tube and homogenized using autoclaved micropistills 
and a 200 µl pipet afterwards to solve all by up and down pipetting. After 5 min 
incubation on ice, 100 µl chloroform were added, samples were vortexed for 30 s and 
incubated for 3 min at room temperature. Centrifugation for 15 min at 4°C and 13000 
rpm followed, then the upper aqueous phase (200 µl) was pipetted into a fresh 1.5 ml 
RNAse free Safelock tube and mixed 1:1 with 70% ethanol. Afterwards, the mix was 
transferred to a RNeasy MinElute spin column and centrifuged for 20 s at 23°C at 
maximum speed. After discarding the flow-through, 700 µl RW1 buffer were added, 
centrifuged for 20 s under the same conditions and flow-through was discarded 
again. The next step was the same, just adding 500 µl RPE buffer. After another step 
with 500 µl RPE buffer and centrifugation for 2 min for washing the spin column 
membrane, centrifugation followed for 1 min as a drying step. The columns were 
placed into new 1.5 ml collection tubes, and 2 times 10 µl RNase free H2O were 
added directly to the center of the spin column membrane and centrifuged for 1 min 
at full speed, respectively, for eluting RNA. Before the RNA was stored at -20°C until 
cDNA synthesis, RNA concentration was measured. For all qPCR studies, RNA 
concentration was detected by an Implen NanoPhotometer (Implen, Munich, 
Germany). Given that just low RNA yields were measured, lidfactor 10 was used. 
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Results were considered as reliable and in a secure range, when RNA purity 
absorption ratio A260/280 nm was in the range of 1.7 up to 2.1.  
 
2.8.4 Reverse transcription 
Reverse transcription is the process of reversely transcribing RNA into its 
complementary DNA (cDNA) by using a reverse transcriptase (RT). Before carrying 
out the cDNA synthesis with the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Foster City, California, USA), the RNA samples’ concentration 
was adjusted to 100 ng/µl. Following manufacturer’s instructions, a master mix (10 µl) 
consisting of 2 µl 10x RT Buffer, 0.8 µl 25x dNTP Mix (100 mM), 2 µl 10x RT 
Random Primers, 1 µl MultiscribeTMReverse Transcriptase and 4.2 µl RNase free 
H2O was prepared and mixed with 10 µl of RNA sample on ice. Every round of      
RT-PCR, additionally, had a negative RNase free H2O control instead of a RNA 
sample. The cDNA synthesis was performed in a thermal cycler (primus96 advanced, 
Peqlab Biotechnologie GmbH, Erlangen, Germany) with a 4-step reaction program 
(initial enzyme activation: 25°C 10 min; reverse transcription: 37°C 120 min; 
termination: 85°C 5 min; cooling 4°C ad infinitum). After dilution of obtained cDNA 1:5 
with RNase free H2O, cDNA was stored at -20°C until further use.  
 
2.8.5 Quantitative real-time PCR (qPCR) 
This method is a combination of amplification and quantification of mRNA to analyze 
and determine gene expression levels of specific genes of interest (Higuchi et al., 
1993). For this purpose, a specific fluorescent reporter dye (QuantiFast SYBR Green 
PCR Kit, Qiagen GmbH) binding to double stranded DNA was used. The 
corresponding fluorescence increases in “real-time”. At the end of the amplification 
process, a melting curve was generated to control the purity of the amplified PCR 
products. The qPCR was conducted in a 384-well plate in the Roche LightCycler® 
480 SW 1.5.1 (Roche Diagnostics, Mannheim, Germany). Each qPCR setup included 
sample duplicates, a negative control (RNase free H2O) and the RT negative control 
(see 2.8.5). Also a pooled standard dilution series (1:1, 1:5; 1:25, 1:50) for every 
gene was prepared as a control for primer functionality and for calculating the 
efficiency. According to the QuantiFast SYBR Green Kit protocol, a master mix (total 
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8 µl) containing 5 µl 2x QuantiFast SYBR Green PCR Master Mix, 1 µl RNase free 
H2O, 1 µl of the specific forward primer and reverse primer plus 2 µl cDNA (1:5) was 
prepared and was loaded on each of the 384-wells. After centrifugation of the plate 
shortly at full speed, the cycling of the LightCycler program was performed in the 
Roche LightCycler® 480 SW 1.5.1 under following conditions of qPCR run: initial 
preincubation phase (95°C, 5 min), amplification of 40 cycles in which after each 
cycle fluorescence was assessed (denaturation at 95°C 10 s; combined annealing 
and extension at 60°C 30 s, 72°C 10 s), melting curve (95°C 5 s, 50°C 10 s) and 
cooling (40°C 30 s). The melting curve was generated to control for primer specificity. 
Data analysis was done with the LightCyclerSoftware 4.0 (Roche Diagnostics, 
Mannheim, Germany). The absolute quantification fit points method was used to 
calculate the respective crossing point (Cp) values, which was done by standardizing 
thresholds and noise bands of housekeeping (HK) and target genes to equal levels. 
According to the 2-ΔΔCT method (Livak and Schmittgen, 2001), the mean Cps of the 
HK genes were used as references to normalize the Cps of candidate genes. HKs 
are necessary as reference genes for every brain region, thus they are involved in 
basal cellular processes, constitutively expressed and should not be capable of being 
influenced by environment. In this study, the mean of two different HKs (B2mg, 
Rpl13a, Polr2b) was used, and the relative fold expression was normalized to the 
mean value of one analyzed group (for microarray LAB or HAB).  
 
2.9 Selection of candidate genes and primer design 
qPCR primers were designed using the Primer blast tool of the NCBI database 
(www.ncbi.nlm.nih.gov) and were based on the sequences provided by the Ensemble 
database (www.ensemble.org). To guarantee the amplification of cDNA only, primers 
were designed to be intron-spanning, if possible, and oligonucleotides were 
purchased from Sigma-Aldrich (Table 2.1).  
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Table 2.1: List of all primer oligonucleotides for quantitative real-time PCR with orientation and 
chromosomal location of the respective gene.  
Gene Chromosome 
Primer 
Orientation 
Sequence 5' --> 3' 
4921530F17Rik Y 
forward CCT GAG TCA CAT TCT GCC CA 
reverse CCA CCA AGG ATG TTG GTG AAT C 
A830006F12Rik 1 
forward AGC ACC ACC GTT AAC CTC AG 
reverse CAG CAG AGG TGA CCA ATC CA 
Adra2c 5 
forward ACT GGT CGG TGA CGC AAG CG 
reverse GCC GGC GGT AGA ACG AGA CG 
Arc 15 
forward AGC CTA CAG AGC CAG GAG AA 
reverse GGT GAT GCC CTT TCC AGA CA 
B2mg 2 
forward CTA TAT CCT GGC TCA CAC TG 
reverse CAT CAT GAT GCT TGA TCA CA 
Cnksr2 X 
forward GGT GAG CAA ATG GTC TCC GA 
reverse TAG CAG CTG GTC TCC ACT GA 
Crh 3 
forward GCA GTG CGG GCT CAC CTA CC 
reverse GGC AGG CAG GAC GAC AGA GC 
Crhr1 11 
forward GCC CCA TGA TCC TGG TCC TGC 
reverse CCA TCG CCG CCA CCT CTT CC 
Egr2 10 
forward CCT CGT CGG TGA CCA TCT TC 
reverse TCG GAT ACG GGA GAT CCA GG 
Egr4 6 
forward CTC TCC AAG CCC ACC GAA G 
reverse AAG CCC AGC TCA AGA AGT CG 
Fos 12 
forward GGC TCT CCT GTC AAC ACA CA 
reverse CTG GTG GAG ATG GCT GTC AC 
Foxp2 6 
forward GCA ACA ACA TCT GCT CAG CC 
reverse CTC CAT GCT TGA TGC CGT TG 
Gabrq X 
forward CAC TTC GAG CTC TCC TCC AG 
reverse ACC ACA GCT TCAT TTG CAC AG 
Hmgn3 9 
forward AGG TGC TAA GGG GAA GAA GG 
reverse GTC CCG AGA GGT ACG TGA AA 
Junb 8 
forward CCC GGA TGT GCA CGA AAA TG 
reverse GTC GTG TAG AGA CAG GCT GC 
Npas4 19 
forward CAC TCG CAA GGG TGT CTT CT 
reverse AAT CCA GGT AGT GCT GCC AC 
Nr3c1 (GR) 18 
forward CAA GGG TCT GGA GAG AGG ACA A 
reverse TAC AGC TTC CAC ACG TCA GC 
Pbx3 2 
forward GTC ACA GAA TGA AAC CGG CG 
reverse GTC TCA TTA GCT GGG GGT CG 
Polr2b 5 
forward CAA GAC AAG GAT CAT ATC TGA TGG 
reverse AGA GTT TAG ACG ACG CAG GTG 
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Rgs9 
exon 1-2 
11 
forward GGG TCC AGA ATG ACG ATC CG 
reverse TCT GCA TGT CCT TCA CCA GG 
Rgs9 
exon 16-17 
11 
forward GAA GTA CGG CGA TCA GTC CA 
reverse TGT CCA TGG TTT TGC CGT CT 
Rpl13a 7 
forward CAC TCT GGA GGA GAA ACG GAA GG 
reverse GCA GGC ATG AGG CAA ACA GTC 
Tacr1 6 
forward GGT AGG GAT TAC ACT GTG GGC 
reverse TGG CGA AGG TAC ACA CAA CC 
YY1 12 
forward ACC TGG CAT TGA CCT CTC 
reverse TTA TCC CTG AAC ATC TTT GT 
 
 
2.10 RNA amplification for microarray 
For array analysis, extracted total RNA from HAB, LAB, HAB-EE and LAB-CMS mice 
(6 per group) was processed strictly according to the instructions of the 
Illumina®TotalPrepTM-96 RNA Amplification Kit (part number AMIL1791, Ambion). 
The protocol started with reverse transcription of 180 ng total RNA to synthesize first 
strand cDNA using T7 Oligo(dT) primers followed by a second strand cDNA 
synthesis to convert the single-stranded cDNA into a double-stranded DNA (dsDNA) 
template for transcription. First strand cDNA synthesis incubation was carried out at 
42°C and second strand cDNA synthesis at 16°C in a thermal cycler (GeneAmp PCR 
System 9700, PE Applied Biosystems, Foster City, California, USA). After purification 
of the dsDNA transcription templates, in vitro transcription to synthesize cRNA was 
done to generate multiple copies of biotinylated cRNA from the double-stranded 
cDNA templates. Therefore, incubation at 37°C was performed for 14 h in a 37°C 
incubation chamber followed by cRNA purification using a PHMT Grantbio thermo-
shaker (Keison, Essex, UK). Biotin-labeled cRNA yield and quality was assessed by 
the Agilent 2100 Bioanalyzer (see 2.8.2).  
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2.11 Array hybridization 
For gene expression profiling of cRNA, Illumina gene expression beadchip array 
(MouseWG-6 v2.0_11278593 Expression BeadChip; Illumina, San Diego, USA) was 
used. This screening method allowed the identification of about 46.000 individual 
transcripts. Six samples were loaded per microarray slide (24 in total). Material and 
reagents were provided by Illumina, and hybridization was performed strictly 
following the manufacturer’s protocol. In short, starting amount for hybridization was 
1500 ng/µl in 10 µl for each sample and was mixed with hybridization buffer. After 
loading each sample onto the designated array field, the slides were put into a 
hybridization oven provided by Illumina and incubated for 16.5 h. BeadChips were 
washed several times with different reagents, then signal was developed with 
streptavidin-Cy3, washed again and dried by centrifugation. A BeadStation scanner 
(Illumina) was used for detecting fluorescence based hybridization signals and 
BeadStudio software (Version 2010.1.0.18378) for analyzing data. Statistical analysis 
is described under 2.13.1. 
 
2.12 Neurogenesis experiment 
To examine the relationship between anxiety-related behavior and neurogenesis, we 
investigated whether a proneurogenic substance (such as memantine) (Akers et al., 
2014) would modulate the anxiety-related/depression-like behavior in HAB mice in 
the same way as EE would do. Therefore, standard-housed female HAB mice were 
treated with memantine hydrochloride (MM, Merck Chemicals GmbH, Schwalbach 
am Taunus, Germany) dissolved in 0.9% NaCl (Fresenius GmbH, Bad Homburg, 
Germany) containing 10% DMSO (Sigma-Aldrich) and injected 25 mg/kg 
(intraperitoneally (i.p.), once per day) to increase neurogenesis in mice (Akers et al., 
2014). For control treatment, 0.9% NaCl containing 10% of DMSO (saline, 25 mg/kg, 
i.p., once per day) was administered to HABs in both standard and enriched 
environment (EE). For labelling newly born cells to measure neurogenesis, mice 
were treated with bromodeoxyuridine (BrdU, Sigma-Aldrich) before behavioral 
phenotyping (Sah et al., 2012).  
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2.12.1 Experimental setup 
Before partial enrichment started at PND 15, the groups were assigned to standard 
or enriched housing with 20 female pups per treatment. At PND 28, all pups were 
weighed and divided into three groups. Mice were separated into standard-housed 
HAB, HAB-MM and enriched-housed HAB-EE groups (7-8 mice per group). The 
injections started at PND 33, with one injection every second day, for six days. Each 
mouse received an i.p. injection each of either DMSO or MM, 25 mg/kg/day for all, 
depending on the assigned group. Weights were recorded before the first, third and 
fifth injection to calculate the dose. At PND 44 and 45, all animals received a BrdU 
injection (50 mg/kg/day) once per day. Six days later, behavioral phenotyping started 
with the OF test followed by the LD test 48 h later to determine anxiety-related 
behavior (described in 2.2.1 and 2.2.3, respectively). As a depression-like behavioral 
test, FST was chosen and followed after one day of resting (described in 2.2.5). All 
mice were deeply anesthetized with an overdose of sodium pentobarbital (Sigma-
Aldrich) and transcardially perfused two hours after the onset of the FST, before 
immunohistochemistry was performed. The experimental time course is shown in  
Fig. 2.11. 
 
 
Figure 2.11: Time course of the neurogenesis experimental setup. Partial enrichment started at 
postnatal day (PND) 15 with 6 h per day in EE, and mice remained in full EE from PND 28 followed by 
a behavioral test battery, including open field (OF), elevated plus-maze (EPM) tests and forced swim 
test (FST). During the time of full EE, mice received intraperitoneally (i.p.) injections of either saline or 
memantine (MM) and 5-bromo-2’-deoxyuridine (BrdU). 
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2.12.2 Immunohistochemistry 
For Immunohistochemistry, animals were deeply anesthetized with an overdose of 
sodium pentobarbital (200 mg/kg, Sigma-Aldrich) two hours after the onset of the 
FST. The animals were then transcardially perfused with 0.9% saline followed by 4% 
paraformaldehyde in 0.1 mol/L phosphate buffered solution (PBS, pH = 7.4). Brains 
were removed and postfixed in 4% paraformaldehyde in PBS at 4°C overnight. A 
Vibratome (Ted-Pella, Redding, California, USA) was used to cut coronal sections 
(50 µm) and were collected in 0.2 M PBS. According to previously described 
protocols (Sah et al., 2012), free-floating coronal sections were processed for BrdU 
and doublecortin (DCX) immunodetection. DCX-positive (DCX+) cells are an 
indication for immature neurons. They were incubated in one of the following primary 
antibodies: rat anti-BrdU (1/350, AbD Serotec, Puchheim, Germany), goat anti-DCX 
C18 (1/250, Santa Cruz Biotechnology, Santa Cruz, California, USA). Incubation in a 
corresponding biotinylated goat anti-rat secondary antibody (1/200, Vector 
Laboratories, Burlingame, California, USA) or rabbit anti-goat secondary antibody 
(1/200, Vector Laboratories) followed subsequently. Avidin-biotin-horseradish 
peroxidase procedure (VECTASTAIN Elite ABC Kit, Vector Laboratories) with      
3,3’-diaminobenzidine (DAB) as chromogen was used to visualize these antigen-
antibody complexes. 
 
2.12.3 Quantification of cells 
One-in-eight series of sections of each brain were stained with DAB. Immunoreactive 
cells were counted using a computer-assisted image analysis system (Nikon E-800 
microscope, CCD video camera, Optronics MicroFire, Goleta, CA, USA; Stereo 
Investigator Software, MicroBrightField Europe e.K., Magdeburg, Germany) 
throughout the rostrocaudal extent of the GCL of the DG (Sah et al., 2012), using a 
20 x or 40 x objective. If the brown-black DAB-stained nucleus was unambiguously 
darker than background staining, which included all cells from low to high intensities 
of staining, a cell was considered as BrdU labeled. The lighting of the microscope 
was optimized for the best visibility of BrdU cells to be analyzed and kept constant for 
all sections. Statistical analysis is described in 2.13.2. 
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2.13 Statistical methods 
2.13.1 Statistical analysis of the microarray experiment 
For statistical analysis of the microarray experiment, Illumina BeadStudio software 
(Version 2010.1.0.18378) was used to analyze the raw fluorescence data or signal 
intensities (BeadSummary Data). This reflects the degree of hybridization of cRNA to 
beads with the corresponding oligonucleotide probe sequences. Further data 
processing was done using R ‘beadarray’ package described by Dunning et al. 
(2007). Array probes that were not different from background fluorescence levels in 
more than two samples were removed. Data was normalized using the ‘vsn’ function 
in R followed by analysis in the Qlucore Omics Explorer. For differential expression 
analyses, normalized data was subjected to a t-test. For clustering all animals, the 
function ‘hclust’ was used. Quality control of microarray data was based on visual 
inspection of scan images, data distributions, internal Illumina controls, pairwise 
scatter plots and statistical outlier detection of samples. One HAB-EE sample was 
detected as outlier and was excluded from all further analysis.  
To correct for multiple testing, obtained p-values were applied to the Benjamini-
Hochberg false discovery rate (FDR) approach and produced q-values, using 
characteristics of the p-value distribution (Benjamini and Hochberg, 1995). HAB vs. 
LAB list was filtered according to both, a >2fold difference in expression and the 
respective q-values (q<0.05), to get the strongest regulated genes and for the 
comparisons HAB vs. HAB-EE and LAB vs. LAB-CMS >1.3 fold and >1.15 fold 
regulation (p<0.05) were applied (Fig. 2.12).  
 
 
Figure 2.12: Microarray data analysis workflow. Statistical steps for analysis of microarray data.  
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2.13.2 Statistical analysis of gene expression, neurogenesis and behavioral 
data 
Data were analyzed by the statistic program SPSS 18.0 (SPSS Inc., Chicago, IL, 
USA), and comparative illustrations of data were created with GraphPad Prism 5. 
Normal distribution was evaluated with the Shapiro-Wilcoxon test and variance 
homogeneity was checked by Levene’s test of variance of the data. Since normal 
distribution was not always required, non-parametric independent comparisons were 
mostly used for statistical analyses. If the data was normally distributed, unpaired t-
test or one-way analysis of variance (ANOVA) was applied followed by the 
appropriate post-hoc test (Bonferroni or Tukey) to correct for multiple comparisons. 
For independent comparison of two samples, the Mann-Whitney U test (MWU) was 
performed, and for analysis of more than two samples the Kruskal-Wallis H test 
(KWH) was applied. If the KWH test was significant, pairwise comparisons were 
performed with the MWU test followed by post-hoc Bonferroni correction. Data with a 
probability of error lower than 5% were accepted as significant. All data are shown as 
mean + standard error of the mean (SEM). In Table 2.2, the different significance 
levels are presented.  
 
Table 2.2: List of the defined significance levels.  
n.s. 
(non-significant) 
T 
(Trend) 
* 
(significant) 
** 
*** 
 
p>0.1 p<0.1 p<0.05 p<0.01 p<0.001 
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2.13.3 Cluster analyses 
The DAVID Bioinformatics tool (version 6.7) is a database for annotation, 
visualization and integrated discovery and was used for cluster analysis of large sets 
of gene and protein lists. Therefore, this tool generated systematically biological 
annotation clusters of differentially expressed genes of the microarray for functional 
enrichment (http://david.abcc.ncifcrf.gov/). Submitting the lists of regulated genes to 
DAVID bioinformatics tool was done by following a given protocol (Huang et al., 
2009). Enrichment scores ≥1.3 of detected clusters were examined as functional 
clusters of the differentially expressed genes having a significant biological impact. 
Every cluster was corrected for multiple testing implemented by Benjamini correction.  
  
Results 
 
45 
 
3 Results 
3.1 Microarray analysis 
Before the microarray-based gene expression profiling for comparing the HAB vs. 
LAB, HAB vs. HAB-EE and LAB vs. LAB-CMS transcriptomes was performed, mice 
had to be behaviorally phenotyped (see 3.1.1, 3.1.2). Gene expression results are 
shown in 3.1.3. 
 
3.1.1 Behavioral tests of microarray animals 
The behavior of animals used for the microarray experiment was assessed in the 
EPM and LD tests. Around 20 male mice per group (HAB, LAB) and treatment were 
tested. Out of these, six mice per group were selected randomly. 
For the EPM test, just in HAB compared to HAB-EE mice a significant difference was 
observed using the non-parametric MWU test in the percentage time spent on the 
open arms (U=182.5, p=0.046, mean ± SEM: HAB: 7.17 ± 1.56, HAB-EE: 11.89 ± 
1.80) indicating an anxiolytic effect of EE. In LAB vs. LAB-CMS no significant 
difference was found in their percentage time spent on the open arms (U=199, 
p=0.403, mean ± SEM: LAB: 62.67 ± 3.38, LAB-CMS: 67.51 ± 3.68) (Fig. 3.1 A). Six 
mice per group were chosen for further microarray analysis. In this case, HAB-EE 
mice spent significantly more time on the open arms of the EPM test (U=1.0, 
p=0.006, mean ± SEM: HAB: 1.45 ± 1.20, HAB-EE: 13.72 ± 2.21). Again, no 
difference was found for LAB compared to LAB-CMS mice in the percentage time 
spent on the open arms of the EPM test (U=13.0, p=0.423, mean ± SEM: LAB: 70.07 
± 4.52, LAB-CMS: 60.57 ± 6.65) (Fig. 3.1 B). 
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Figure 3.1: Effect of enriched environment (EE) and chronic mild stress (CMS) on anxiety-
related behavior in the elevated plus-maze (EPM) test. The comparison is shown (A) for all tested 
mice (N (HAB) = 24, N (HAB-EE) = 23, N (LAB-CMS) = 18, N (LAB) = 26) and (B) for mice selected for 
microarray analysis (N = 6 per group). Data are shown as mean + SEM, (* p<0.05, ** p<0.01). 
 
 
Results in the LD test corroborate changes observed in the EPM test, an anxiolytic 
effect of EE. HAB-EE mice spent significantly more time in percentage in the light 
compartment compared to HAB mice (U=129.5, p=0.001, mean ± SEM: HAB: 2.46 ± 
1.20, HAB-EE: 12.35 ± 2.50). LAB-CMS mice had a significantly decreased 
percentage time spent in the light compartment (U=131.5, p=0.014, mean ± SEM: 
LAB: 43.76 ± 2.98, LAB-CMS: 33.54 ± 1.98) (Fig. 3.2 A). Almost the same results are 
shown for the animals used in the microarray analysis. HAB-EE mice spent in 
percentage more time in the light compartment showing a less anxious phenotype 
compared to HAB mice (U=5.5, p=0.037, mean ± SEM: HAB: 1.00 ± 0.68, HAB-EE: 
8.83 ± 5.65). For LAB compared to LAB-CMS mice a trend was observed showing 
that stressed LAB mice spent less time in the light compartment (U=7, p=0.078, 
mean ± SEM: LAB: 49.35 ± 5.20, LAB-CMS: 36.47 ± 3.79) (Fig. 3.2 B). 
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Figure 3.2: Effect of enriched environment (EE) and chronic mild stress (CMS) on anxiety-
related behavior in the light-dark box (LD) test. The comparison is shown (A) for all tested mice (N 
(HAB) = 24, N (HAB-EE) = 23, N (LAB-CMS) = 18, N (LAB) = 26) and (B) for mice selected for 
microarray analysis (N = 6 per group). Data are shown as mean + SEM, (T p< 0.1, * p<0.05,               
** p<0.01). 
 
3.1.2 Behavioral phenotyping for qPCR validation 
For validation of differentially expressed candidate genes in the microarray-based 
profiling, qPCR analysis was done. For this analysis, mice were taken from an 
independent batch of animals with HAB mice housed either in standard or in enriched 
environment as well as unstressed or stressed LAB mice. In this case, again male 
mice were taken. At the beginning, more mice were tested in three different anxiety 
tests to reveal the possible effects of the EE manipulation in HAB mice. For qPCR 
analysis, eight mice per group were taken according to their behavior. To assess 
anxiety-related behavior, always more than one behavioral test should be performed 
to converge verification of a phenotype (face validity) (Cryan et al., 2002). Behavioral 
data for OF, EPM and LD tests for HAB and HAB-EE comparison is shown in Fig. 3.3 
until Fig. 3.5. 
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In the OF test, no significant difference was observed for the parameter ‘total 
distance traveled’. In all mice, no difference in locomotion (U=162, p=0.266, mean ± 
SEM: HAB: 7.84 ± 1.74 m, HAB-EE: 8.27 ± 1.05 m, Fig. 3.3 A) and in percentage 
time spent in the inner zone (U=183, p=0.443, mean ± SEM: HAB: 0.37 ± 0.23, HAB-
EE: 0.57 ± 0.26) was detected. The eight selected mice also showed no significant 
difference in their locomotion (U=18, p=0.141, mean ± SEM: HAB: 4.87 ± 1.45 m, 
HAB-EE: 8.86 ± 1.65 m) and in their percentage time spent in the inner zone (U=30, 
p=0.783, mean ± SEM: HAB: 0.10 ± 0.08, HAB-EE: 0.58 ± 0.40).  
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Figure 3.3: No effect of enriched environment (EE) on locomotion in the open field (OF) test. The 
comparison is shown (A) for all tested mice (N (HAB) = 17, N (HAB-EE) = 24) and (B) for mice 
selected for qPCR validation (N = 8 per group). Data are shown as mean + SEM. 
 
 
EE-treated mice exhibited significantly lower anxiety-related behavior in the EPM test 
as indicated by a higher percentage of time spent on the open arms (U=65, p<0.001, 
mean ± SEM: HAB: 3.07 ± 1.06, HAB-EE: 10.35 ± 1.48). The same significant 
difference was shown for animals chosen for qPCR analysis (U=0, p<0.001, mean ± 
SEM: HAB: 0.03 ± 0.03, HAB-EE: 11.27 ± 2.34) (Fig. 3.4). 
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Figure 3.4: Effect of enriched environment (EE) on anxiety-related behavior in the elevated plus-
maze (EPM) test. The comparison is shown (A) for all tested mice (N (HAB) = 17, N (HAB-EE) = 24) 
and (B) for mice selected for qPCR validation (N = 8 per group). Data are shown as mean + SEM,   
(*** p<0.001). 
 
 
The third test for assessing anxiety-related behavior was the LD test. EE induced a 
significant increase in their percentage of time spent in the light compartment of the 
LD test (U=16.0, p<0.001, mean ± SEM: HAB: 1.29 ± 0.57, HAB-EE: 9.25 ± 1.42,  
Fig. 3.5 A; U=0, p<0.001, mean ± SEM: HAB: 0 ± 0, HAB-EE: 9.53 ± 2.41,             
Fig. 3.5 B).  
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Figure 3.5: Effect of enriched environment (EE) on anxiety-related behavior in the light-dark box 
(LD) test. The comparison is shown (A) for all tested mice (N (HAB) = 17, N (HAB-EE) = 24) and (B) 
for mice selected for qPCR validation (N = 8 per group). Data are shown as mean + SEM,                
(*** p<0.001). 
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For these animals, no depression-like tests were conducted, because previous 
experiments only showed a weak effect of EE in males as assessed in TST and FST 
(Markt, 2012). 
 
Male LAB and LAB-CMS mice for qPCR validation were selected from the parental 
generation of the transgenerational approach (N=7), and behavioral data are shown 
in 3.2.2. For these mice, EPM and LD tests were used as anxiety-related tests and 
TST and FST for assessing depression-like behavior.  
 
3.1.3 Microarray detected differentially expressed candidate genes 
Using microarray-based gene expression profiling of BLA tissue from HAB, LAB, 
HAB-EE and LAB-CMS animals, covering the whole genome, three lists with 
candidate genes were generated (see 3.1.3.3 – 3.1.3.5).  
 
3.1.3.1 ‘Hclust’ function 
To test how the animals used in this study were related to each other and if there is a 
distinct separation of the two selective breeding lines, we performed a hierarchical 
clustering. The ‘hclust’ function of the ‘R’ statistical software package showed that 
HAB and LAB mice are hierarchically different, which was based on the expression 
distances of all samples. Due to missing quality, one HAB-EE sample was detected 
as an outlier and was excluded from further analysis (Fig. 3.6). 
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Figure 3.6: Cluster Dendrogram of all 23 samples shown in hierarchical clustering. The numbers 
indicate the microarray identifiers. Red are HAB samples, blue LAB samples, and the dots show the 
treatments, enriched environment (EE) or chronic mild stress (CMS), (N (HAB/LAB/LAB-CMS) = 6,    
N (HAB-EE) = 5).  
 
3.1.3.2 Cluster analysis of microarray candidate genes  
To classify significantly differentially expressed candidate genes of the microarray 
study, annotational clustering was performed. Therefore, the DAVID Bioinformatics 
Database for functional annotation clustering was used and was done for three lists: 
HAB vs. LAB, HAB vs. HAB-EE, LAB vs. LAB-CMS. The investigated gene clusters 
were named based on the shared/associated functions of the genes they contained. 
(http://david.abcc.ncifcrf.gov/). 
For the functional clustering of HAB vs. LAB, five significantly enriched gene clusters 
were identified (Table 3.1). In the first cluster, 22 genes were found to contribute to 
different functions in the mitochondrion. Envelope or membrane associated genes 
are clustered under it. The second cluster contained 21 genes, which are all 
associated with nucleotide, ATP or nucleoside binding. Nine genes were attributed to 
the third enriched cluster, acting as cytoplasmic or membrane-bound vesicles. The 
fourth annotational cluster comprised eight genes involved in various functions of the 
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immune system. The fifth enriched cluster included five genes, all of them respond to 
various environment stimuli such as light, radiation or abiotic changes.  
 
Table 3.1: Significantly enriched gene clusters of 138 genes differentially expressed between 
HAB vs. LAB in the basolateral amygdala. Clusters were detected using the functional annotation 
tool of the DAVID Bioinformatics Database. Genes are sorted in alphabetical order contained in the 
particular clusters, genes in bold letters are detected in both microarray experiments (Czibere et al., 
2011), and were validated in the qPCR follow-up experiment. Genes listed in the respective gene 
cluster are sorted in alphabetical order. (No. = gene cluster number; % indicates the proportion of 
genes contributing to the respective cluster among the 138 differentially expressed genes). 
No. 
Functional 
association 
Enrichment 
score 
Genes % 
1 Mitochondrion 1.8 
1300010F03Rik, 
4930455C21Rik, Abca2, 
Aldh3a2, Cox6a2, Ctsb, 
Cttnbp2, Cyb5, Dut, Fxc1, 
Hsp90ab1, Kcnh1, Mff, 
Mipep, Mosc2, Mrps27, 
Mtif2, Ndufa13, Slc25a3, 
Slc25a17, Slc25a18, Syne1 
17.1 
2 
Nucleotide/  
ATP binding 
1.7 
1300010F03Rik, Abca2, 
Atp8a1, Cbwd1, Ddr1, Dgkq, 
Ehd3, Gnaq, 
Gtpbp4,Hsp90ab1, Kras, 
LOC100044756, Mkks, 
Mtif2, Ndufa13, Nek3, 
Pip4k2a, Rnps1, Ttbk1, Ttl, 
Ube2l 
18.0 
3 Vesicles 1.6 
2400003C14Rik, Abca2, 
Ahcy, Atp8a1, Ccdc88a, 
Ctsb, Cttnbp2, Ehd3, 
Hsp90ab1 
8.1 
4 Immune response 1.5 
Cxadr, Fcrls, Fstl5, H2-T10, 
H2-T23, H2-Q5, 
LOC100044190, 
LOC100047788 
2.7 
5 Stimulus response 1.4 
Apbb1, Ercc5, Kras, Mkks, 
Sdf4 
3.6 
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The submitted list of genes differentially expressed between HAB vs. HAB-EE 
showed five significant clusters fulfilling enrichment scores ≥ 1.3 (Table 3.2). The first 
cluster counted eight genes, all parts of lipoproteins or the palmitate associated 
pathway. The second functional cluster consisted of eight genes, which are anchored 
to the cell membrane via the gpi-anchor or are acting with lipoproteins. All 14 genes 
of the third cluster interact with the plasma membrane or receptor complexes. Seven 
genes were assorted to the third cluster, as they are involved in functions related to 
the postsynaptic membrane, cell junction and cytoskeleton. The last significant 
cluster contained six genes connected to protein activity or protein binding.  
 
Table 3.2: Significantly enriched gene clusters of 78 genes differentially expressed between 
HAB vs. HAB-EE in the basolateral amygdala. Clusters were detected using the functional 
annotation tool of the DAVID Bioinformatics Database. Genes are sorted in alphabetical order 
contained in the particular clusters, genes in bold letters are detected in both microarray experiments 
(Czibere et al., 2011), and underlined bold written genes are validated in the qPCR follow-up 
experiment. Genes listed in the respective gene cluster are sorted in alphabetical order. (No. = gene 
cluster number; % indicates the proportion of genes contributing to the respective cluster among the 
78 differentially expressed genes). 
No. 
Functional 
association 
Enrichment 
score 
Genes % 
1 
Lipoprotein/ palmitate 
associated pathway 
1.8 
Cdh13, Dlg4, Efna5, 
Lpl, Lypd1, Sstr2, 
Tacr1, Wnt5a 
11.4 
2 
Lipoprotein/ gpi-
anchor 
1.6 
Cdh13, Dlg4, Efna5, 
Lpl, Lypd1, Sstr2, 
Tacr1, Wnt5a 
11.4 
3 
Plasma membrane/ 
receptor complex 
1.5 
Arc, Cd83, Cdh13, 
Dlg4, Dok3, Ecel1, 
Evpl, Gabrq, Glra2, 
Itga11, Itgbl1, Kctd6, 
Rgs9, Synpo 
20.0 
4 
Postsynaptic 
membrane 
1.4 
Arc, Dlg4, Evpl, Gabrq, 
Glra2, Mid2, Synpo 
7.1 
5 Protein activity 1.3 
Cdh13, Fos, Foxp2, 
Gpd1, Junb, Npas4 
8.6 
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For LAB vs. LAB-CMS, all detected functional clusters in 67 genes had enrichment 
scores < 1 and failed to be significant according to the criteria set.  
 
3.1.3.3 Identification of differentially expressed genes between HAB vs. LAB 
The first list revealed 138 differentially regulated genes between HAB and LAB mice 
in the BLA (q<0.05; 2fold). We compared these potential candidates with a 
microarray-based gene expression profiling done 20 generations ago in whole brain 
tissue (Czibere et al., 2011) and, remarkably, the same candidate genes were 
coming up to be differentially expressed. These genes were also investigated in the 
first microarray and the follow-up qPCR experiment. Therefore, we only focused on 
these overlapping genes shown in Fig. 3.7. Two genes (Enpp5, Stx3) were 
oppositely regulated compared to the first conducted microarray experiment. Stx3 
proved to be regulated in the opposite way in the qPCR analysis from Czibere et al. 
(2011). The largest expression difference is shown in Ctsb, and it is significantly 
higher expressed in LAB compared to HAB mice (p=4.52x10-7). Detailed results of 
these genes detected in the microarray from this thesis are shown in Table 3.3. 
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Figure 3.7: Gene expression profiles for HAB vs. LAB mice in the basolateral amygdala as 
detected by both microarray analysis and at least one confirmation by qPCR. Data are shown as 
mean value, (N (HAB, LAB, LAB-CMS) = 6, N (HAB-EE) = 5; *** p<0.001). 
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Table 3.3: Differentially expressed genes detected in both microarray experiments and 
validated at least once with qPCR analysis in whole brain tissue and the basolateral amygdala. 
Fold changes of the microarray (MA) marked with # indicate an up-regulation in HAB vs. LAB mice, (N 
(HAB, LAB, LAB-CMS) = 6, N (HAB-EE) = 5; *** p<0.001). 
Gene Gene name 
Fold 
change 
MA 
p-value significance 
Ctsb cathepsin B 14.433 4.52E-07 *** 
Enpp5 
ectonucleotide 
pyrophosphatase/ 
phosphodiesterase 5 
10.024 2.21E-05 *** 
Slc25a17 
solute carrier family 25 
(mitochondrial carrier, 
peroxisomal membrane 
protein), member 17 
2.391 1.63E-06 *** 
Abca2 
ATP-binding cassette,  
sub-family A (ABC1), 
member 2 
3.800# 1.44E-07 *** 
Stx3 syntaxin 3 4.601# 1.68E-07 *** 
Ttbk1 tau tubulin kinase 1 4.563# 6.02E-06 *** 
 
3.1.3.4 Identification of differentially expressed genes between HAB vs. HAB-
EE 
The second list detected 78 differentially expressed genes between HAB and HAB-
EE (p<0.05, 1.3 fold). In order to confirm differential expression, selected genes were 
chosen for follow-up qPCR experiments. 14 genes were selected based on their 
adjusted p-values in the microarray or their connection to anxiety or psychiatric 
diseases (Fig. 3.8). Two genes were confirmed by qPCR (Fos, Gabrq), with Fos 
showing a significantly different regulation in the opposite way as expected. For the 
other twelve selected genes, no different regulation was confirmed by qPCR. Hmgn3 
was added to analyze as an interesting gene, which was shown to be differentially 
expressed by Chekmareva et al. (2014).  
Detailed results of the selected genes detected in the new microarray and chosen for 
qPCR analysis are shown in Table 3.4. Therefore, ddCT values were standardized 
by normalizing to the HAB ddCT group mean. For Rgs9, two different primer 
pairs/assays were designed (Rgs9 exon 1-2, Rgs9 exon 16-17), given that two 
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transcript variants in the sequence were not overlapping. For all qPCR analyses, the 
non-parametric MWU test was performed.  
 
A
83
00
06
F1
2R
ik
49
21
53
0F
17
R
ik
G
ab
rq
Fo
xp
2
P
bx
3
R
gs
9
Ta
cr
1
A
rc
C
nk
sr
2
E
gr
2
E
gr
4
Fo
s
Ju
nb
N
pa
s4
0
1
2
3
** **
*
**** *
*
*
*
**
HAB
HAB-EE
Microarray HAB vs. HAB-EE
**
re
la
ti
v
e
 f
o
ld
 e
x
p
re
s
s
io
n
 
Figure 3.8: Selected gene expression profiles of 14 genes for HAB vs. HAB-EE mice in the 
basolateral amygdala from the microarray analysis. These were used for qPCR analysis only. 
Data are shown as mean value, (N (HAB) = 6, N (HAB-EE) = 5, * p<0.05, ** p<0.01). 
 
 
Detailed results of the microarray experiment and the follow-up qPCR analysis for all 
validated genes are shown in Table 3.4. 
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Table 3.4: Differentially expressed genes detected in the microarray experiment and their 
validation by qPCR analysis in the basolateral amygdala. Fold changes of the microarray (MA) 
marked with # indicate an up-regulation in HAB vs. HAB-EE mice. Statistically significant results are 
indicated by bold letters, (n.s. = not significant, n.a. = not available, MWU = Mann-Whitney U test), 
(MA: N (HAB) = 6; N (HAB-EE) = 5; qPCR: N (HAB, HAB-EE) = 8; n.s. p>0.1, * p<0.05). 
Gene Gene name 
Fold 
change 
MA 
p-
value 
MWU 
qPCR 
significance 
HAB-
EE 
mean 
± SEM 
HAB 
mean 
± SEM 
Arc 
activity 
regulated 
cytoskeletal-
associated 
protein 
2.42 0.208 n.s. 
0.81  
± 0.11 
1.00  
± 0.11 
Cnksr2 
connector 
enhancer of 
kinase 
suppressor of 
Ras 2 
1.36 0.401 n.s. 
1.40  
± 0.34 
1.00  
± 0.11 
Egr2 
early growth 
response 2 
1.48 0.141 n.s. 
0.76  
± 0.11 
1.00  
± 0.10 
Egr4 
early growth 
response 4 
1.43 0.916 n.s. 
0.96  
± 0.10 
1.00  
± 0.13 
Fos 
FBJ 
osteosarcoma 
oncogene 
1.58 0.036 * 
0.55  
± 0.09 
1.00  
± 0.15 
Foxp2 forkhead box P2 1.31# 0.462 n.s. 
0.80  
± 0.27 
1.00  
± 0.30 
Gabrq 
gamma-
aminobutyric 
acid (GABA) A 
receptor, 
subunit theta 
1.36# 0.012 * 
0.56  
± 0.17 
1.00  
± 0.15 
Hmgn3 
high mobility 
group 
nucleosomal 
binding domain 
3 
n.a. 0.674 n.s. 
0.93  
± 0.14 
1.00  
± 0.13 
Junb Jun-B oncogene 1.40 0.248 n.s. 
0.88  
± 0.11 
1.00  
± 0.11 
4921530
F17Rik 
Riken cDNA 
4921530F17 
gene 
1.43# 0.834 n.s. 
1.02  
± 0.22 
1.00  
± 0.18 
Npas4 
neuronal PAS 
domain protein 
4 
1.70 0.916 n.s. 
0.86  
± 0.16 
1.00  
± 0.23 
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Pbx3 
similar to 
PBX3a; pre B-
cell leukemia 
transcription 
factor 3 
1.35# 0.208 n.s. 
0.82  
± 0.22 
1.00  
± 0.24 
Rgs9 
1st 
assay 
regulator of G-
protein signaling 
9 
1.74# 
0.817 n.s. 
1.29  
± 0.50 
1.00  
± 0.27 
Rgs9 
2nd 
assay 
0.355 n.s. 
1.11  
± 0.58 
1.00  
± 0.21 
Tacr1 
tachykinin 
receptor 1 
1.46# 0.529 n.s. 
0.81  
± 0.18 
1.00  
± 0.22 
A830006
F12Rik 
Riken cDNA 
A830006F12 
gene 
1.47# 0.753 n.s. 
1.07  
± 0.19 
1.00  
± 0.11 
 
3.1.3.5 Identification of differentially expressed genes between LAB vs. LAB-
CMS 
The comparison between LAB and LAB-CMS revealed 67 genes, which showed 
significant expression difference (p<0.05, 1.15 fold). Three genes (Cnksr2, Foxp2, 
Adra2c) were chosen for qPCR analysis. Cnksr2 and Foxp2 (Fig. 3.9) were also 
present in the comparison between HAB and HAB-EE as potential candidates for 
plasticity. Hmgn3 was again added as an interesting gene to analyze. Additionally, 
Fos and Gabrq were analyzed due to the fact that they were detected as differentially 
expressed in HAB vs. HAB-EE in qPCR described before (3.1.3.4). In qPCR 
analyses, ddCT values were standardized by normalizing to the LAB group mean 
(Table 3.5). For all qPCR analyses, MWU test was performed.  
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Figure 3.9: Selected gene expression profiles of two genes for LAB vs. LAB-CMS mice in the 
basolateral amygdala from the microarray analysis. These genes were used for subsequent qPCR 
analysis. Data are shown as mean value, (N (LAB, LAB-CMS) = 6; * p<0.05). 
 
Table 3.5: Differentially expressed genes detected in the microarray experiment and their 
validation by qPCR analysis in the basolateral amygdala. All fold changes of the microarray (MA) 
indicate an up-regulation in LAB vs. LAB-CMS mice. Statistically significant results are indicated by 
bold letters, (n.s. = not significant, n.a. = not available, MWU = Mann-Whitney U test), (MA: N (LAB, 
LAB-CMS) = 6; qPCR: N (LAB, LAB-CMS) = 7; n.s. p>0.1, * p<0.05). 
Gene Gene name 
Fold 
change 
MA 
p-value 
MWU 
qPCR 
significance 
LAB-CMS 
mean 
± SEM 
LAB 
mean 
± SEM 
Adra2c 
adrenergic 
receptor, 
alpha 2c 
1.159 0.898 n.s. 
1.08  
± 0.26 
1.00  
± 0.14 
Cnksr2 
connector 
enhancer of 
kinase 
suppressor of 
Ras 2 
1.193 0.018 * 
0.79  
± 0.04 
1.00  
± 0.06 
Fos 
FBJ 
osteosarcoma 
oncogene 
n.a. 0.225 n.s. 
1.33  
± 0.16 
1.00  
± 0.14 
Foxp2 
forkhead box 
P2 
1.211 0.406 n.s. 
1.15  
± 0.23 
1.00  
± 0.39 
Gabrq 
gamma-
aminobutyric 
acid (GABA) 
A receptor, 
subunit theta 
n.a. 0.482 n.s. 
0.56  
± 0.06 
1.00  
± 0.31 
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Hmgn3 
high mobility 
group 
nucleosomal 
binding 
domain 3 
n.a. 0.277 n.s. 
0.85  
± 0.10 
1.00  
± 0.09 
 
 
A summary of the three candidate genes of plasticity, which were differentially 
regulated between HAB and HAB-EE or LAB and LAB-CMS mice in the analyzed 
BLA, is shown in Fig. 3.10. Since Foxp2 was detected in both comparisons in the 
microarray experiment, results are shown in the summary as well.  
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Figure 3.10: Summary of gene expression profiles of four interesting candidate genes of 
plasticity. Gene expression is shown for HAB vs. HAB-EE and for LAB vs. LAB-CMS mice in the 
basolateral amygdala. Data are shown as mean + SEM, (N (HAB, HAB-EE) = 8, N (LAB, LAB-     
CMS) = 7; n.s. p>0.1, * p<0.05). 
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3.1.3.6 Identification of differentially expressed genes in the cingulate cortex  
Additionally, selected genes of the microarray were analyzed by qPCR analysis in 
another important region known to be associated with anxiety-related behavior, the 
cingulate cortex (Cg) (Shin and Liberzon, 2010) (Table 3.6 and 3.7).  
There, only Fos was found to be differentially regulated between HAB and HAB-EE 
with a higher expression in HAB mice, as already seen in the BLA.  
 
 
Table 3.6: Analyzed genes in qPCR in the cingulate cortex between HAB vs. HAB-EE. 
Statistically significant result for Fos is indicated by bold letters, (n.s. = not significant, MWU = Mann-
Whitney U test), (N (HAB, HAB-EE) = 8; n.s. p>0.1, * p<0.05). 
Gene 
p-value MWU 
qPCR 
significance 
HAB-EE 
mean 
± SEM 
HAB 
mean 
± SEM 
Arc 0.674 n.s. 0.78 ± 0.09 1.00 ± 0.19 
Cnksr2 0.248 n.s. 0.81 ± 0.10 1.00 ± 0.15 
Fos 0.016 * 0.53 ± 0.06 1.00 ± 0.16 
Foxp2 0.294 n.s. 0.92 ± 0.11 1.00 ± 0.36 
Gabrq 0.753 n.s. 0.86 ± 0.09 1.00 ± 0.23 
Hmgn3 0.753 n.s. 0.92 ± 0.07 1.00 ± 0.20 
 
 
Table 3.7: Analyzed genes in qPCR in the cingulate cortex between LAB vs. LAB-CMS.          
(n.s. = not significant, MWU = Mann-Whitney U test), (N (LAB, LAB-CMS) = 7; n.s. p>0.1). 
Gene 
p-value MWU 
qPCR 
significance 
LAB-CMS 
mean 
± SEM 
LAB 
mean 
± SEM 
Cnksr2 0.949 n.s. 1.09 ± 0.23 1.00 ± 0.13 
Fos 0.224 n.s. 1.28 ± 0.13 1.00 ± 0.17 
Foxp2 0.482 n.s. 1.09 ± 0.18 1.00 ± 0.14 
Gabrq 0.749 n.s. 1.31 ± 0.38 1.00 ± 0.15 
Hmgn3 0.225 n.s. 1.09 ± 0.07 1.00 ± 0.11 
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3.2 Transgenerational transmission of CMS 
In this study, we wanted to investigate transgenerational effects of anxiety-related 
and depression-like behavior. Therefore, we performed CMS as described earlier in 
2.3.2. For validation of the microarray, we took male LAB (Co) and LAB-CMS (CMS) 
mice from the parental generation. The influence of CMS on the breeding success for 
the next generation is shown in 3.2.1., followed by behavioral tests: EPM, LD tests 
for assessing anxiety-related behavior, and TST, FST for determining depression-like 
behavior for each generation separately.  
 
3.2.1 Breeding  
First of all, we examined whether CMS treatment had any influence on the breeding 
success of the first and second generations. To create the parental generation, LAB 
mothers were not stressed at all, but at PND 15 the CMS treatment with maternal 
separation was started. Here, no difference was observed in the breeding, thus the 
mothers were not stressed during the mating and first two nursing phases. The 
parental generation had to be mated twicely as the breeding was not successful. This 
was independent of the CMS treatment as no significant difference was observed 
between CMS-treated and Co parents regarding breeding success (Table 3.8).  
 
Table 3.8: Breeding success from parental (P) generation of generating generation F1 and F1 to 
F2.  
 
breeding line/  
treatment 
pairs mated litters alive 
number of 
pups raised 
P 
Co 2 
matings 
16 3 26 
CMS 25 9 79 
F1 
Co-Co 
 
12 5 29 
CMS-Co 
 
18 10 60 
CMS-CMS 
 
16 8 62 
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3.2.2 Parental (P) generation 
The EPM test was performed to measure locomotion and anxiety-related behavior in 
males and females, and if CMS treatment had an impact on behavior. Male and 
female data was processed separately. First of all, CMS-treated female mice showed 
a decrease of their locomotor activity on the EPM test as indicated by total distance 
traveled (U=171, p=0.001), whereas in male mice no difference was observed 
(U=224, p=0.980) (Fig. 3.11). No significant difference in anxiety-related behavior 
measured by the parameters ‘percentage time spent on the open arms’ and ‘number 
of entries to the open arms’ were shown for neither male nor female. CMS-treated 
female mice required significantly more time to the first entry to the open arms 
compared to standard Co female mice (U=231.5, p=0.021). In male mice, again, no 
difference was observed (U=211, p=0.730). Detailed results of the EPM test are 
summarized in Table 3.9.  
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Figure 3.11: Effect of chronic mild stress (CMS) in the elevated plus-maze (EPM) test for male 
and female LAB mice. CMS induced in female mice (A) a decrease of total distance traveled in the 
EPM test and (B) a higher latency to the first entry to the open arms. Data are shown as mean + SEM, 
(male: N (Co) = 18, N (CMS) = 25; female: N = 27 per group; * p<0.05, ** p<0.01). 
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Table 3.9: Behavioral data of the elevated plus-maze test between CMS and Co groups for both 
sexes. Statistical significance detected with Mann-Whitney U test (MWU), (n.s. p>0.1, * p<0.05,         
** p<0.01).  
 
 
total distance 
traveled [m] 
open arm 
entries [n] 
latency to the first 
entry to the open 
arms [s] 
time spent on the 
open arms [%] 
Co 
male 9.94 ± 0.56 8.00 ± 1.51 30.11 ± 4.27 54.24 ± 3.09 
female 12.60 ± 0.60 6.70 ± 0.61 27.39 ± 3.21 58.00 ± 3.12 
CMS 
male 10.05 ± 0.58 6.08 ± 0.50 32.90 ± 4.45 57.49 ± 2.87 
female 10.19 ± 0.52 5.93 ± 0.40 51.93 ± 8.58 53.12 ± 3.02 
MWU 
male 
0.980 0.358 0.730 0.313 
n.s. n.s. n.s. n.s. 
female 
0.001 0.236 0.021 0.373 
** n.s. * n.s. 
 
 
In the LD test, a significant difference in anxiety-related behavior was detected for 
male and female mice. The CMS group spent significantly less percentage in the light 
compartment (male: U=94, p=0.002, mean ± SEM: Co: 47.46 ± 3.30, CMS: 31.53 ± 
2.78; female: U=129, p<0.001, mean ± SEM: Co: 49.95 ± 2.16, CMS: 37.34 ± 2.58), 
as well as showed less entries to the light compartment than the Co group for both 
genders (male: t(49)=2.869, p=0.007, mean ± SEM: Co: 10.35 ± 1.13, CMS: 6.72 ± 
0.71; female: t(52)=4.525, p<0.001, mean ± SEM: Co: 12.96 ± 0.98, CMS: 7.63 ± 
0.66), respectively (Fig. 3.12). In the parameter ‘latency to the first entry to the light 
compartment’, only in female CMS mice a later entry was shown (female: U=169, 
p=0.001, mean ± SEM: Co: 12.91 ± 4.14 s, CMS: 36.99 ± 11.20 s). Male mice 
showed no difference in this parameter (male: U=161, p=0.187, mean ± SEM: Co: 
31.10 ± 10.74 s, CMS: 41.73 ± 12.21 s). 
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Figure 3.12: Effect of chronic mild stress (CMS) in the light-dark box test for male and female 
LAB mice. CMS induced (A) a decrease of time spent in the light compartment in male and female 
mice, (B) a lower number of entries to the light compartment in male and female mice, and (C) a later 
entry to the light compartment in female mice, but not in male mice. Data are shown as mean + SEM, 
(male: N (Co) = 17, N (CMS) = 25); female: N = 27 per group; ** p<0.01, *** p<0.001). 
 
 
The TST was one of the two tests used to assess depression-like behavior. CMS-
treated female mice spent significantly more time immobile compared to Co mice 
(female: U=206, p=0.042, mean ± SEM: Co: 65.42 ± 11.64 s, CMS: 105.79 ± 17.53 s) 
and also showed a trend for more immobile episodes (female: U=218, p=0.069, 
mean ± SEM: Co: 5.74 ± 0.67, CMS: 6.91 ± 0.57) during the 6-min testing time, 
which reflects a passive coping style in a stressful situation rather than an emotional 
state (Fig. 3.13). In male mice, no significant difference in neither time immobile 
(male: U=160, p=0.587, mean ± SEM: Co: 54.84 ± 9.36 s, CMS: 59.96 ± 8.08 s) nor 
in the number of immobile episodes (male: U=123, p=0.101, mean ± SEM: Co: 5.00 ± 
0.54, CMS: 6.57 ± 0.75) was observed. The parameter ‘latency to first immobility’ 
was significantly different in male and female mice and was increased in the CMS 
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group (male: U=78, p=0.003, mean ± SEM: Co: 30.00 ± 16.07 s, CMS: 81.33 ±  
20.91 s; female: U=171.5, p=0.007, mean ± SEM: Co: 19.03 ± 9.03 s, CMS: 50.74 ±    
13.18 s).  
 
0
50
100
150 Co
CMS
male female
*
(A)
 t
im
e
 i
m
m
o
b
il
e
 [
s
]
0
2
4
6
8 CMS
Co
male female
(B)
T
im
m
o
b
il
e
 e
p
is
o
d
e
s
 [
n
]
0
50
100
150 Co
CMS
male female
**
**
(C)
la
te
n
c
y
 t
o
 f
ir
s
t 
im
m
o
b
il
it
y
 [
s
]
 
Figure 3.13: Effect of chronic mild stress (CMS) in the tail-suspension test for male and female 
LAB mice. CMS induced (A) an increase of depression-like behavior in female mice, indicated by a 
higher time immobile and (B) a higher number of immobile episodes in the female group compared to 
Co mice. No difference was observed in males for both parameters. (C) CMS treatment showed in 
male and female mice a higher latency to first immobility. Data are shown as mean + SEM,         
(male: N (Co) = 17, N (CMS) = 21; female: N (Co) = 27, N (CMS) = 23; T p<0.1, * p<0.05, ** p<0.01). 
 
Furthermore, we tested the CMS- and Co-treated mice in the FST to reveal 
depression-like behavior. Although, we could find a pro-depressive effect of CMS 
treatment in the TST for female mice, no significant difference was observed neither 
in floating time in male and female mice in the FST (male: U=174.5, p=0.330; female: 
U=240, p=0.113), nor in swimming time (male: U=210, p=0.949; female: U=268, 
p=0.291) nor struggling time (male: U=170, p=0.276; female: U=297.5, p=0.617) 
assessing active coping style. Both, CMS-treated male and female mice had a higher 
number of floating episodes reflected by a trend (male: U=143.5, p=0.075; female: 
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U=221, p=0.051), and a decreased latency to the first floating was shown in the 
female CMS group (male: U=162.5, p=0.200; female: U=236, p=0.097) (Fig. 3.14). 
Both of these parameters corroborate a pro-depressive effect of CMS as shown in 
the TST (Table 3.10).  
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Figure 3.14: Effect of chronic mild stress (CMS) in the forced swim test for male and female LAB 
mice. A trend towards (A) a higher number of floating episodes of CMS mice compared to Co mice in 
both sexes and (B) a decreased latency to first floating in female, but not in male CMS mice, was 
observed. Data are shown as mean + SEM, (male: N (Co) = 17, N (CMS) = 25; female: N (Co) = 24,  
N (CMS) = 27; T p<0.1, * p<0.05, ** p<0.01). 
 
 
Table 3.10: Behavioral data of forced swim test between CMS and Co groups for both sexes. 
Statistical difference was detected with Mann-Whitney U test (MWU) or unpaired t-test,                   
(n.s. p>0.1, T p<0.1).  
  struggling 
time [s] 
swimming 
time [s] 
floating time 
[s] 
floating 
episodes [n] 
latency to first 
floating [s] 
Co 
male 
70.28 
± 8.37 
233.94 
± 11.85 
56.98 
± 13.21 
4.76 
± 0.78 
159.33 
± 26.74 
female 
66.60 
± 6.74 
240.54 
± 8.33 
52.81 
± 10.71 
4.38 
± 0.61 
168.80 
± 17.78 
CMS 
male 
59.38 
± 6.48 
234.54 
± 9.40 
68.37 
± 9.77 
7.24 
± 0.91 
121.72 
± 19.86 
female 
63.51 
± 5.55 
222.10 
± 13.66 
76.54 
± 11.23 
6.04 
± 0.61 
135.46 
± 18.47 
MWU/ 
t-test 
male 
0.304 0.949 0.330 0.075 0.200 
n.s. n.s. n.s. T n.s. 
female 
0.723 0.291 0.113 0.051 0.097 
n.s. n.s. n.s. T T 
 
 
 
Results 
68 
 
Taken together, the CMS paradigm with several unpredictable mild stressors during 
their early development could change the anxiety-related and depression-like 
behavior in males and females of the parental generation, which is reflected by an 
anxiogenic and pro-depressive effect in both sexes. Therefore, CMS represents a 
reliable basis for further experiments on the influence of environmental manipulation, 
e.g., the transmission to next generations.  
 
3.2.3 F1 generation 
To test if CMS-induced changes in behavior can be transmitted from one generation 
to the next, we applied the CMS paradigm for two subsequent generations. To select 
the P animals for mating, the behavior in the EPM and LD tests was considered. The 
F1 generation consisted of three different groups: Co-Co, CMS-Co, CMS-CMS. 
 
In the EPM test, male and female CMS-CMS groups for both sexes showed a 
significant difference in their total distance traveled compared to the Co-Co group 
(male: F(2,34)=7.156, p=0.003; female: F(2,43)=16.849, p<0.001). Decreased locomotor 
activity was found for the CMS-CMS group compared to unstressed controls (male: 
Co-Co vs. CMS-Co: p=1.000, Co-Co vs. CMS-CMS: p=0.016, CMS-Co vs. CMS-
CMS: p=0.005; female: Co-Co vs. CMS-Co: p=0.207, Co-Co vs. CMS-CMS: 
p=0.008, CMS-Co vs. CMS-CMS: p<0.001, Fig. 3.15). Male CMS-Co mice have a 
higher number of entries to the open arms of the EPM test compared to CMS-CMS 
mice, which was not detected in female mice (male: F(2,34)=3.941, p=0.029, post-hoc: 
Co-Co vs. CMS-Co: p=0.541, Co-Co vs. CMS-CMS: p=0.361, CMS-Co vs. CMS-
CMS: p=0.027; female: F(2,43)=0.206, p=0.814, post-hoc: Co-Co vs. CMS-Co: 
p=1.000, Co-Co vs. CMS-CMS: p=1.000, CMS-Co vs. CMS-CMS: p=1.000). No 
difference for both sexes was found neither in the parameters ‘percentage time spent 
on the open arms’ of the EPM test (male: KWH: H(2)=1.251, p=0.535; female: KWH: 
H(2)=2.892, p=0.235) nor in ‘latency to the first open arm entry’ (male: KWH: 
H(2)=2.709, p=0.258; female: KWH: H(2)=1.006, p=0.605). Detailed results 
measured in the EPM test of generation F1 are shown in Table 3.11.  
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Figure 3.15: Effect of chronic mild stress (CMS) in the elevated plus-maze test for male and 
female mice of generation F1. (A) Both sexes of CMS-CMS mice had a lower total distance traveled 
in the EPM test compared to Co-Co and CMS-Co groups, and in (B) male mice a lower number of 
open arm entries was observed. Data are shown as mean + SEM, (male: N (Co-Co) = 14, N (CMS-
Co) = 9, N (CMS-CMS) = 14; female: N (Co-Co) = 11, N (CMS-Co) = 18, N (CMS-CMS) = 17;              
* p<0.05, ** p<0.01, *** p<0.001). 
 
Table 3.11: Behavioral data of the elevated plus-maze test in F1 mice for both sexes.  
Statistical difference was detected with one-way ANOVA or Kruskal-Wallis H test (KWH) followed by 
an appropriate post-hoc test, (n.s. p>0.1, * p<0.05, ** p<0.01, *** p<0.001).  
 
 
total distance 
traveled [m] 
open arm 
entries [n] 
latency to the 
first entry to the 
open arms [s] 
time spent on 
the open arms 
[%] 
Co-Co 
male 13.38 ± 0.55 5.57 ± 0.60 33.21 ± 6.83 61.41 ± 3.50 
female 13.94 ± 1.01 5.36 ± 0.77 38.02 ± 4.22 52.51 ± 4.15 
CMS-Co 
male 14.22 ± 1.00 6.89 ± 0.75 29.02 ± 2.66 48.89 ± 5.18 
female 15.97 ± 0.75 5.83 ± 0.66 37.17 ± 6.81 59.25 ± 3.15 
CMS-CMS 
male 10.58 ± 0.69 4.21 ± 0.60 46.07 ± 13.54 61.47 ± 5.47 
female 10.42 ± 0.48 5.29 ± 0.62 44.61 ± 7.33 55.75 ± 4.77 
ANOVA/KWH 
male 
0.003 0.036 0.605 0.235 
** * n.s. n.s. 
female 
<0.001 0.858 0.258 0.535 
*** n.s. n.s. n.s. 
Co-Co 
vs. CMS-Co 
male 1.000 0.422 
  
female 0.207 
   
Co-Co 
vs. CMS-CMS 
male 0.016 0.154 
  
female 0.008 
   
CMS-Co 
vs. CMS-CMS 
male 0.005 0.039 
  
female <0.001 
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The second test for assessing anxiety-related behavior was the LD test. Here, the 
test corroborated the findings of the EPM test in the parameter ‘number of entries to 
the light compartment’, but in this case in females and not in males (male: KWH: 
H(2)=2.746, p=0.253, Co-Co vs. CMS-Co: p=0.704, Co-Co vs. CMS-CMS: p=0.253, 
CMS-Co vs. CMS-CMS: p=0.407; female: KWH: H(2)=7.943, p=0.019, Co-Co vs. 
CMS-Co: p=0.257, Co-Co vs. CMS-CMS: p=0.386, CMS-Co vs. CMS-CMS: 
p=0.014). Furthermore, a significant difference in the latency to the first entry to the 
light compartment was observed in male, but not in female mice (male: KWH: 
H(2)=6.884, p=0.032; female: KWH: H(2)=2.192, p=0.334). The significance could 
not withstand Bonferroni correction and resulted in just a trend (male: Co-Co vs. 
CMS-Co: p=0.298, Co-Co vs. CMS-CMS: p=0.073, CMS-Co vs. CMS-CMS: p=0.089; 
female: Co-Co vs. CMS-Co: p=0.291, Co-Co vs. CMS-CMS: p=0.126, CMS-Co vs. 
CMS-CMS: p=0.792) (Fig. 3.16). 
No difference for either sex was found in their percentage time spent in the light 
compartment of the LD test (male: F(2,34)=0.496, p=0.613; female: F(2,43)=0.955, 
p=0.393) (Table 3.12).  
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Figure 3.16: Effect of chronic mild stress (CMS) in the light-dark box test in male and female 
mice of generation F1. (A) Female CMS-CMS mice had a lower number of entries to the light 
compartment compared to CMS-Co group, and (B) male CMS-CMS group showed a higher latency to 
the first entry to the light compartment. Data are shown as mean + SEM, (male: N (Co-Co) = 14,        
N (CMS-Co) = 9, N (CMS-CMS) = 14; female: N (Co-Co) = 11, N (CMS-Co) = 18, N (CMS-CMS) = 17;  
T p<0.1, * p<0.05). 
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Table 3.12: Behavioral data of the light-dark box test in F1 mice for both sexes.              
Statistical difference was detected with one-way ANOVA or Kruskal-Wallis H test (KWH) followed by 
an appropriate post-hoc test, (n.s. p>0.1, * p<0.05).  
 
 
entries to the 
light 
compartment [n] 
latency to the first 
entry to the light 
compartment [s] 
time spent in the 
light compartment 
[%] 
Co-Co 
male 9.79 ± 0.90 19.14 ± 4.04 38.09 ± 3.07 
female 10.18 ± 1.08 13.51 ± 2.87 40.78 ± 2.98 
CMS-Co 
male 8.89 ± 1.30 14.96 ± 5.02 41.73 ± 4.93 
female 11.78 ± 0.76 22.08 ± 5.35 39.24 ± 2.87 
CMS-CMS 
male 8.07 ± 0.32 37.96 ± 7.11 42.11 ± 2.39 
female 8.47 ± 0.70 21.42 ± 4.32 44.18 ± 2.31 
ANOVA/KWH 
male 
0.253 0.032 0.613 
n.s. * n.s. 
female 
0.019 0.334 0.393 
* n.s. n.s. 
Co-Co vs. CMS-Co 
male 
 
0.298 
 
female 0.257 
  
Co-Co vs. CMS-CMS 
male 
 
0.073 
 
female 0.193 
  
CMS-Co vs. CMS-CMS 
male 
 
0.089 
 
female 0.014 
  
 
 
To characterize depression-like behavior, we used the TST. It corroborated the 
findings in the EPM test, in which stressed mice showed decreased locomotor activity 
in the TST. In more detail, male CMS-CMS mice spent significantly more time 
immobile compared to Co-Co and CMS-Co groups, whereas in female mice no 
significant difference was found (male: KWH: H(2)=10.998, p=0.004, Co-Co vs. CMS-
Co: p=0.488, Co-Co vs. CMS-CMS: p=0.010, CMS-Co vs. CMS-CMS: p=0.020; 
female: KWH: H(2)=1.268, p=0.531) (Fig. 3.17). The parameters ‘number of immobile 
episodes’ (male: KWH: H(2)=4.239, p=0.120; female: KWH: H(2)=0.317, p=0.854) 
and ‘latency to first immobility’ were not significantly different (male: KWH: 
H(2)=2.933, p=0.231; female: KWH: H(2)=0.410, p=0.815) (Table 3.13).  
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Figure 3.17: Effect of chronic mild stress (CMS) in the tail-suspension test in male and female 
mice of generation F1. Male CMS-CMS mice spent more time immobile compared to Co-Co and 
CMS-Co group. Data are shown as mean + SEM, (male: N (Co-Co) = 14, N (CMS-Co) = 9,                 
N (CMS-CMS) = 14; female: N (Co-Co) = 10, N (CMS-Co) = 17, N (CMS-CMS) = 17; * p<0.05,           
** p<0.01). 
 
Table 3.13: Behavioral data of the tail-suspension test in F1 mice for both sexes.            
Statistical difference was detected with Kruskal-Wallis H test (KWH) followed by an appropriate post-
hoc test, (n.s. p>0.1, ** p<0.01).  
 
 
time immobile [s] immobile episodes [n] 
latency to first 
immobility [s] 
Co-Co 
male 62.36 ± 12.68 6.57 ± 0.64 66.65 ± 25.73 
female 51.66 ± 9.33 6.80 ± 1.12 54.84 ± 24.56 
CMS-Co 
male 54.16 ± 17.71 5.22 ± 1.19 49.37 ± 28.81 
female 65.73 ± 11.35 7.29 ± 0.73 36.71 ± 12.09 
CMS-CMS 
male 127.47 ± 14.86 8.21 ± 0.70 12.29 ± 5.07 
female 109.83 ± 23.48 7.24 ± 1.11 51.44 ± 22.10 
KWH 
male 
0.004 0.120 0.231 
** n.s. n.s. 
female 
0.531 0.854 0.815 
n.s. n.s. n.s. 
Co-Co vs. CMS-Co 
male 0.488 
  
female 
   
Co-Co vs. CMS-CMS 
male 0.010 
  
female 
   
CMS-Co vs. CMS-CMS 
male 0.020 
  
female 
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In the FST, only a trend in male F1 mice was found for the parameters ‘time 
struggling’ (male: F(2,33)=2.729, p=0.080) and ‘time swimming’ (male: F(2,33)=2.991, 
p=0.064). For female mice, a trend was revealed only in time struggling (female: 
F(2,40)=2.467, p=0.098). No significant difference was observed in the FST neither for 
time floating, nor number of floating episodes nor the latency to first floating in both 
sexes (Table 3.14).  
 
Table 3.14: Behavioral phenotyping in the forced swim test for F1 mice for both sexes.  
Statistical difference was detected with one-way ANOVA or Kruskal-Wallis H test (KWH) followed by 
an appropriate post-hoc test, (n.s. p>0.1, T p<0.1).  
 
 
time 
struggling [s] 
time 
swimming [s] 
time 
floating [s] 
floating 
episodes [n] 
latency to first 
floating [s] 
Co-Co 
male 
78.90 
± 9.69 
271.74 
± 9.04 
10.91 
± 3.15 
3.29 
± 0.81 
249.89 
± 27.81 
female 
59.95 
± 6.74 
289.55 
± 8.81 
11.65 
± 5.27 
2.82 
± 1.13 
263.55 
± 35.29 
CMS-Co 
male 
59.51 
± 6.42 
274.38 
± 12.00 
27.71 
± 9.90 
4.00 
± 1.38 
216.06 
± 29.65 
female 
81.89 
± 7.51 
259.96 
± 11.25 
19.17 
± 6.81 
3.27 
± 0.67 
194.27 
± 20.68 
CMS-CMS 
male 
95.49 
± 10.76 
240.16 
± 12.22 
26.22 
± 8.00 
6.00 
± 1.68 
193.04 
± 23.86 
female 
66.49 
± 6.37 
264.90 
± 7.96 
30.76 
± 8.44 
6.29 
± 1.52 
194.93 
± 23.26 
ANOVA/ 
KWH 
male 
0.080 0.064 0.225 0.515 0.279 
T T n.s. n.s. n.s. 
female 
0.098 0.109 0.185 0.177 0.218 
T n.s. n.s. n.s. n.s. 
Co-Co vs. 
CMS-Co 
male 0.662 1.000 
   
female 0.128 
    
Co-Co vs. 
CMS-CMS 
male 0.657 0.119 
   
female 1.000 
    
CMS-Co vs. 
CMS-CMS 
male 0.080 0.168 
   
female 0.322 
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3.2.4 F2 generation 
In the second generation (F2) treated with CMS, the CMS-CMS-CMS male and 
female mice exhibited significantly lower locomotor activity in the EPM test as 
indicated by less total distance traveled (male: F(2,70)=3.669, p=0.016; female: 
F(2,54)=7.779, p<0.001) (Fig. 3.18 A). Furthermore, the male and female CMS-CMS-
CMS group revealed a significantly lower number of open arm entries (male: KWH: 
H(3)=10.227, p=0.017; female: KWH: H(3)=19.917, p<0.001) and a significantly 
increased latency to the first entry to the open arms (male: KWH: H(3)=14.382, 
p=0.002; female: KWH: H(3)=13.610, p=0.003), indicative for more anxiety-related 
behavior. A conspicuous feature is shown in female Co-Co-Co mice in the number of 
open arm entries, in which the Co-Co-Co compared to CMS-CMS-CMS group also 
showed a low number of open arm entries. Moreover, significance of female Co-Co-
Co vs. CMS-CMS-CMS and CMS-CMS-Co vs. CMS-CMS-CMS in latency to the first 
entry to the open arms did not survive post-hoc testing. Although the key criterion for 
anxiety-related behavior measured in the EPM test is the percentage time spent on 
the open arms, in F2 generation no significant difference was detected in this 
parameter (male: KWH: H(3)=2.910, p=0.406; female: KWH: H(3)=3.505, p=0.320) 
(Table 3.15). This showed that even if a difference was observed in the parental 
generation, no difference has to be found in the second generation, and more than 
one test for assessing anxiety-related behavior has to be performed.  
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Figure 3.18: Effect of chronic mild stress (CMS) in the elevated plus-maze test in male and 
female mice of generation F2. (A) Female CMS-CMS-CMS mice showed a significantly lower 
locomotive behavior compared to all other groups, male CMS-CMS-CMS showed a difference 
compared to CMS-CMS-Co group. (B) CMS-CMS-CMS of both males and females revealed a 
significantly lower number of open arm entries, also shown in female Co-Co-Co group.                     
(C) Significantly higher latency to the first entry to the open arms was observed in CMS-CMS-CMS 
group. Data are shown as mean + SEM, (male: N (Co-Co-Co) = 12, N (CMS-Co-Co) = 26,                  
N (CMS-CMS-Co) = 18, N (CMS-CMS-CMS) = 18; female: N (Co-Co-Co) = 8, N (CMS-Co-Co) = 27,  
N (CMS-CMS-Co) = 11, N (CMS-CMS-CMS) = 12; T p<0.1, * p<0.05, ** p<0.01, *** p<0.001). 
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Table 3.15: Behavioral phenotyping in the elevated plus-maze test for F2 mice for both sexes. 
Statistical difference was detected with one-way ANOVA or Kruskal-Wallis H test (KWH) followed by 
an appropriate post-hoc test, (n.s. p>0.1, * p<0.05, ** p<0.01, *** p<0.001). 
 
 
total distance 
traveled [m] 
open arm 
entries [n] 
latency to the 
first entry to the 
open arms [s] 
time spent on the 
open arms [%] 
Co-Co-Co 
male 11.73 ± 0.83 14.75 ± 2.03 13.01 ± 2.92 50.86 ± 4.28 
female 14.96 ± 1.11 8.25 ± 1.51 16.15 ± 2.13 61.30 ± 6.03 
CMS-Co-Co 
male 12.30 ± 0.40 15.23 ± 1.65 14.51 ± 1.69 50.96 ± 2.67 
female 13.55 ± 0.56 16.59 ± 1.21 13.57 ± 1.45 52.00 ± 3.25 
CMS-CMS-Co 
male 13.63 ± 0.52 15.06 ± 1.78 11.58 ± 1.39 54.98 ± 4.07 
female 14.50 ± 0.68 14.45 ± 1.82 18.35 ± 3.13 52.17 ± 3.25 
CMS-CMS-CMS 
male 11.31 ± 0.45 9.17 ± 1.13 30.07 ± 4.89 57.69 ± 4.31 
female 10.04 ± 0.60 8.08 ± 1.33 34.69 ± 5.74 54.41 ± 6.42 
ANOVA/KWH 
male 
0.016 0.017 0.002 0.406 
* * ** n.s. 
female 
<0.001 <0.001 0.003 0.320 
*** *** ** n.s. 
Co-Co-Co vs. 
CMS-Co-Co 
male 1.000 1.000 0.583 
 
female 1.000 0.011 0.578 
 
Co-Co-Co vs. 
CMS-CMS-Co 
male 0.140 1.000 0.949 
 
female 1.000 0.061 0.804 
 
Co-Co-Co vs. 
CMS-CMS-CMS 
male 1.000 0.088 0.009 
 
female 0.001 0.983 0.154 
 
CMS-Co-Co vs. 
CMS-CMS-Co 
male 0.319 1.000 0.163 
 
female 1.000 0.574 0.403 
 
CMS-Co-Co vs. 
CMS-CMS-CMS 
male 0.881 0.026 0.004 
 
female 0.002 0.002 0.003 
 
CMS-CMS-Co 
vs. CMS-CMS-
CMS 
male 0.014 0.053 0.001 
 
female 0.001 0.045 0.169 
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Furthermore, in the LD test, used as another test for anxiety-related behavior, male 
and female mice exhibited a significant difference in several parameters. In males of 
the CMS-CMS-CMS group, a trend compared to the CMS-Co-Co group was 
observed in the parameter ‘percentage time spent in the light compartment’ 
(F(3,70)=2.433, p=0.047, post-hoc: CMS-Co-Co vs. CMS-CMS-CMS: p=0.078), which 
was not shown for all the other group comparisons. For female mice, in the same 
parameter, the CMS-Co-Co group showed a trend to the Co-Co-Co group and the 
CMS-CMS-CMS group and a significant difference to the CMS-CMS-Co group 
(F(3,54)=7.489, p=0.003; Co-Co-Co vs. CMS-Co-Co: p=0.086, CMS-Co-Co vs. CMS-
CMS-Co: p=0.007, CMS-Co-Co vs. CMS-CMS-CMS: p=0.096, others: p>0.1). 
Moreover, a difference was found in males concerning the latency to the first entry to 
the light compartment (KWH: H(3)=8.847, p=0.031), but none in the number of 
entries to the light compartment (KWH: H(3)=3.715, p=0.294). In females the 
opposite was the case. A significant difference was detected in the number of entries 
to the light compartment (KWH: H(3)=19.082, p<0.001), but none for latency to the 
first entry to the light compartment (KWH: H(3)=3.150, p=0.369) (Fig. 3.19 and   
Table 3.16).  
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Figure 3.19: Effect of chronic mild stress (CMS) in the light-dark box test in male and female 
mice of generation F2. (A) CMS-CMS-CMS mice showed a trend for higher percentage time spent in 
the light compartment compared to CMS-Co-Co group, and (B) a significant difference in the number 
of entries to the light compartment was found in female mice in CMS-CMS-CMS and CMS-Co-Co 
compared to Co-Co-Co and CMS-CMS-Co groups, but not for males. (C) Male CMS-Co-Co had a 
significantly increased latency to the first entry to the light compartment compared to CMS-CMS-Co, 
which was not found in female mice. Data are shown as mean + SEM, (male: N (Co-Co-Co) = 12,      
N (CMS-Co-Co) = 26, N (CMS-CMS-Co) = 18, N (CMS-CMS-CMS) = 18; female: N (Co-Co-Co) = 8,  
N (CMS-Co-Co) = 27, N (CMS-CMS-Co) = 11, N (CMS-CMS-CMS) = 12; T p<0.1, * p<0.05, ** p<0.01, 
*** p<0.001). 
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Table 3.16: Behavioral phenotyping in the light-dark box test for F2 mice for both sexes. 
Statistical difference was detected with one-way ANOVA or Kruskal-Wallis H test (KWH) followed by 
an appropriate post-hoc test, (n.s. p>0.1, * p<0.05, ** p<0.01, *** p<0.001).  
 
 
entries to the 
light 
compartment [n] 
latency to the first entry to 
the light compartment [s] 
time spent in the 
light 
compartment [%] 
Co-Co-Co 
male 10.58 ± 1.33 20.91 ± 5.26 29.32 ± 5.39 
female 12.88 ± 1.75 21.63 ± 9.57 44.88 ± 3.56 
CMS-Co-Co 
male 8.35 ± 0.73 42.45 ± 7.78 28.86 ± 3.31 
female 9.81 ± 0.87 34.29 ± 10.76 29.27 ± 3.33 
CMS-CMS-Co 
male 11.50 ± 1.13 18.26 ± 4.55 37.64 ± 3.29 
female 14.73 ± 0.83 17.00 ± 6.40 47.96 ± 4.35 
CMS-CMS-CMS 
male 9.28 ± 0.74 29.15 ± 9.75 41.61 ± 3.80 
female 7.75 ± 0.54 21.31 ± 4.34 42.49 ± 3.99 
ANOVA/KWH 
male 
0.294 0.031 0.047 
n.s. * * 
female 
<0.001 0.369 0.003 
*** n.s. ** 
Co-Co-Co vs. CMS-
Co-Co 
male 
 
0.343 1.000 
female 0.311 
 
0.086 
Co-Co-Co vs. CMS-
CMS-Co 
male 
 
0.794 1.000 
female 0.280 
 
1.000 
Co-Co-Co vs. CMS-
CMS-CMS 
male 
 
0.849 0.283 
female 0.025 
 
1.000 
CMS-Co-Co vs. 
CMS-CMS-Co 
male 
 
0.038 0.504 
female 0.010 
 
0.007 
CMS-Co-Co vs. 
CMS-CMS-CMS 
male 
 
0.309 0.078 
female 0.221 
 
0.096 
CMS-CMS-Co vs. 
CMS-CMS-CMS 
male 
 
0.980 1.000 
female <0.001 
 
1.000 
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In F2 mice, no pro-depressive effect was found in the TST. None of the three 
parameters ‘time immobile’, ‘number of immobile episodes’ nor ‘latency to first 
immobility’, assessing depression-like behavior, were significantly different        
(Table 3.17).  
 
Table 3.17: Behavioral phenotyping in the tail-suspension test for F2 mice for both sexes.       
No significant differences were observed, (male: N (Co-Co-Co) = 12, N (CMS-Co-Co) = 24, N (CMS-
CMS-Co) = 18, N (CMS-CMS-CMS) = 18; female: N (Co-Co-Co) = 8, N (CMS-Co-Co) = 27, N (CMS-
CMS-Co) = 11, N (CMS-CMS-CMS) = 12; n.s. p>0.1). 
 
 
time immobile [s] immobile episodes [n] 
latency to first 
immobility [s] 
Co-Co-Co 
male 61.94 ± 13.67 6.83 ± 0.93 27.18 ± 16.53 
female 75.21 ± 16.05 7.13 ± 0.77 39.16 ± 23.77 
CMS-Co-Co 
male 61.38 ± 10.43 6.50 ± 0.79 22.16 ± 10.70 
female 54.57 ± 7.35 5.07 ± 0.49 68.79 ± 22.73 
CMS-CMS-Co 
male 46.68 ± 6.96 6.39 ± 0.96 24.96 ± 12.44 
female 58.81 ± 16.53 6.09 ± 0.97 9.63 ± 7.81 
CMS-CMS-CMS 
male 72.10 ± 13.37 7.00 ± 0.71 24.81 ± 12.62 
female 75.86 ± 19.52 6.67 ± 0.89 38.63 ± 27.54 
KWH 
male 0.518 0.791 0.662 
female 0.675 0.213 0.174 
 
n.s. n.s. n.s. 
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In the FST of F2 mice, no change in depression-like and stress-coping behaviors in 
any of the four groups, neither male nor female were seen during the 6-min test 
paradigm. No significant difference was observed in the parameters ‘struggling time’, 
‘swimming time’ nor ‘floating time’ neither in the ‘number of floating episodes’ nor 
‘latency to first floating’ (Table 3.18).  
 
Table 3.18: Behavioral phenotyping in the forced swim test for F2 mice for both sexes.            
No significant differences were observed, (male: N (Co-Co-Co) = 11, N (CMS-Co-Co) = 24,                
N (CMS-CMS-Co) = 18, N (CMS-CMS-CMS) = 18; female: N (Co-Co-Co) = 8, N (CMS-Co-Co) = 27,  
N (CMS-CMS-Co) = 11, N (CMS-CMS-CMS) = 12; n.s. p<0.1). 
 
 
struggling 
time [s] 
swimming 
time [s] 
floating 
time [s] 
floating 
episodes [n] 
latency to first 
floating [s] 
Co-Co-Co 
male 
65.75  
± 8.77 
280.49  
± 9.50 
15.34  
± 4.56 
4.36  
± 0.81 
143.87 ± 
28.44 
female 
52.81  
± 13.73 
293.45  
± 15.36 
15.41  
± 3.37 
3.63  
± 1.19 
135.01 ± 
31.33 
CMS-Co-Co 
male 
68.77  
± 6.52 
275.97  
± 6.01 
17.34  
± 3.92 
4.79  
± 0.74 
177.16 ± 
20.47 
female 
67.29  
± 6.20 
264.7  
± 6.20 
29.58  
± 6.60 
4.26  
± 0.55 
186.39 ± 
19.98 
CMS-CMS-Co 
male 
61.20  
± 6.59 
272.55  
± 8.95 
28.13  
± 7.06 
5.65  
± 1.07 
156.76 ± 
23.24 
female 
56.79  
± 9.23 
268.62  
± 13.63 
36.52  
± 12.37 
6.36  
± 1.44 
172.57 ± 
35.34 
CMS-CMS-CMS 
male 
81.38  
± 7.42 
250.26  
± 9.98 
30.20  
± 8.75 
5.06  
± 0.99 
196.49 ± 
27.95 
female 
62.57  
± 9.95 
254.07  
± 17.07 
45.63  
± 16.00 
5.17  
± 1.13 
177.44 ± 
33.35 
KWH 
male 0.154 0.137 0.577 0.819 0.433 
female 0.652 0.529 0.856 0.453 0.704 
 
n.s. n.s. n.s. n.s. n.s. 
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3.2.5 Basal CORT in generation F2 
As described earlier by Sotnikov et al. (2013), there were significantly higher basal 
CORT levels in stressed mice compared to non-stressed mice, delayed HPA 
reactivity and stronger feedback regulation.  
Here, basal CORT of male and female mice of generation F2 was measured in blood 
plasma by means of radioimmunoassay. In male mice, the basal plasma CORT was 
significantly different between all four groups, which was reflected by a trend in 
female mice (KWH: male: H(3)=27.828, p<0.001, female: H(3)=7.250, p=0.064; 
mean ± SEM: male: Co-Co-Co: 20.29 ± 9.28 ng/ml, CMS-Co-Co: 12.56 ± 7.00 ng/ml, 
CMS-CMS-Co: 4.83 ± 1.09 ng/ml, CMS-CMS-CMS: 48.85 ± 7.05 ng/ml, female: Co-
Co-Co: 20.05 ± 5.93 ng/ml, CMS-Co-Co: 32.80 ± 3.20 ng/ml, CMS-CMS-Co: 28.58 ± 
7.47 ng/ml, CMS-CMS-CMS: 55.45 ± 12.00 ng/ml) (Fig. 3.20). In the group of all 
three stressed generations (CMS-CMS-CMS) of male mice compared to control (Co-
Co-Co) group, a significantly increased CORT level was found (Co-Co-Co vs. CMS-
CMS-CMS: U=30, p=0.007; CMS-Co-Co vs. CMS-CMS-CMS: U=25, p<0.001; CMS-
CMS-Co vs. CMS-CMS-CMS: U=7, p<0.001), whereas for females a difference was 
observed (U=16, p=0.033), which did not survive post-hoc test. In male mice, a trend 
was observed between Co-Co-Co and CMS-Co-Co, as well as a significant 
difference was shown compared to CMS-CMS-Co (Co-Co-Co vs. CMS-Co-Co: U=64, 
p=0.068; Co-Co-Co vs. CMS-CMS-Co: U=36, p=0.023), but between CMS-Co-Co 
and CMS-CMS-Co no difference was found (U=103, p=0.382). Basal CORT levels 
are already different, indicating that CMS is inducing different HPA axis regulation.  
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Figure 3.20: Effect of chronic mild stress (CMS) on basal plasma corticosterone level in male 
and female mice of generation F2. A significant difference was found in males, but not in females. 
Data are shown as mean + SEM, (male: N (Co-Co-Co) = 13, N (CMS-Co-Co) = 18, N (CMS-CMS-Co) 
= 14, N (CMS-CMS-CMS) = 15; female: N (Co-Co-Co) = 8, N (CMS-Co-Co) = 26,  N (CMS-CMS-Co) 
= 10, N (CMS-CMS-CMS) = 10; T p<0.1, * p<0.05, ** p<0.01, *** p<0.001). 
 
3.2.6 Correlation analysis of candidate genes  
In order to determine the degree of correlation between the behavior on the LD test 
and the differential gene expression levels of all three generations of the 
transgenerational approach, we selected male mice according to their behavior from 
low to high anxiety between 0% and 60% time spent in the light compartment of the 
LD test. This parameter was used as an indicator of anxiety and showed robust 
differences after CMS manipulation. Several genes (Crhr1, Crh, GR, YY1, Cnksr2), 
known to be involved in stress and showing differences in earlier studies (Sotnikov et 
al., 2014a), were measured by qPCR in both the BLA and PVN. The correlation was 
calculated to specify its correlation coefficient r, and the relative expression of the 
gene of interest was plotted against the parameter ‘percentage time spent in the light 
compartment’. The determined correlation coefficients constituted a significant effect 
in the CMS-Co-Co group for Crhr1 expression in the BLA (r=-0.6970, p=0.031;      
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Fig. 3.21). This suggests that more anxious mice have a higher expression of Crhr1 
in the BLA. No other correlation was detected.  
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Figure 3.21: Correlation in the CMS-Co-Co group of the relative expression of Crhr1 in the 
basolateral amygdala with the percentage time spent in the light compartment. Data are shown 
as mean + SEM, (N (CMS-Co-Co) = 10; * p<0.05, 0.5 < r < 0.7: moderate correlation).  
 
3.3 Effects of EE or memantine (MM) on anxiety-related/depression-like 
behavior and neurogenesis  
3.3.1 Behavioral tests 
First of all, to assess the changes in neurogenesis, we performed behavioral testing 
to investigate the effect of environmental manipulation combined with a 
pharmacological approach for potential increase of neurogenesis.  
EE is described in chapter 3.1.2 to affect anxiety-related behavior in HAB mice, 
which we could confirm independently of pharmacological treatment, since HAB and 
HAB-EE received identical injections of saline. A behavioral test battery was 
performed comprising OF, LD tests and FST to assess behavioral changes. EE as 
well as MM treatment induced no effect on locomotion in the OF test indicated by the 
parameter ‘total distance traveled’ (F(2,18)=1.399, p=0.272, mean ± SEM: HAB: 9.51 ± 
2.28 m, HAB-MM: 16.89 ± 3.81 m, HAB-EE: 12.72 ± 2.67 m; Fig. 3.22 A). In the LD 
test, a significant increase in the percentage time spent in the light compartment was 
observed in HAB-MM and HAB-EE mice compared to HAB mice (F(2,18)=22.806, 
p<0.001, HAB vs. HAB-MM: p=0.001, HAB vs. HAB-EE: p<0.001, mean ± SEM: 
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HAB: 10.20 ± 2.64, HAB-MM: 31.83 ± 2.03, HAB-EE: 37.93 ± 3.50; Fig. 3.22 B). 
Between the groups HAB-MM and HAB-EE no difference was detected in the 
percentage time spent in the light compartment (HAB-MM vs. HAB-EE: p=0.407). 
Furthermore, no significant effect on the floating time in the FST was observed, 
indicating no effect on depression-like behavior of EE or MM treatment (F(2,18)=0.611, 
p=0.554, mean ± SEM: HAB: 88.71 ± 16.74 s, HAB-MM: 114.18 ± 29.12 s, HAB-EE: 
85.23 ± 14.04 s; Fig. 3.22 C).  
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Figure 3.22: Effects of enriched environment (EE) and injection of memantine (MM) in HAB mice 
in different behavioral tests. Three main parameters measured in the performed behavioral tests are 
shown: (A) total distance traveled in the open field (OF) test, (B) percentage time spent in the light 
compartment in the light-dark box (LD) test, and (C) time floating in the forced swim test (FST). Data 
are shown as mean + SEM, (N (HAB) = 7, N (HAB-MM) = 5, N (HAB-EE) = 9; ** p<0.01, *** p<0.001).  
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3.3.2 Neurogenesis 
We wanted to investigate these two manipulations (described in chapter 2.3.1 and 
3.3.1) on neurogenesis in HAB mice. Both treatments, environmental manipulation as 
well as a pharmacological treatment with MM showed an increase in the number of 
BrdU+ cells surviving in the DG (F(2,18)=5.635, p=0.013, mean ± SEM: HAB: 11.96 ± 
0.74, HAB-MM: 15.27 ± 0.53, HAB-EE: 15.44 ± 0.90; Fig. 3.23 A, 3.24). As shown 
earlier (Sah, 2012), EE showed a significant influence on the survival of newly born 
cells in the DG in comparison to standard-housed HAB mice, here treated with saline 
(HAB vs. HAB-EE: p=0.015). Additionally, injection of MM in the standard-housed 
HAB (HAB-MM) mice revealed an increase in the survival of newly born cells 
compared to HAB mice (HAB vs. HAB-MM: p=0.049). No difference between the 
number of BrdU+ cells between HAB-MM and HAB-EE group was observed (HAB-
MM vs. HAB-EE: p=0.998).  
Furthermore, DCX was used as a marker of the immature neurons. Similarly to 
BrdU+ cells, a higher number of DCX+ cells were observed in HAB-MM and HAB-EE 
groups compared to the group treated with saline, indicating a higher number of 
immature neurons in the DG of the hippocampus (F(2,18)=7.932, p=0.003, mean ± 
SEM: HAB: 155.23 ± 4.55, HAB-MM: 200.42 ± 14.11, HAB-EE: 200.41 ± 9.10; HAB 
vs. HAB-MM: p=0.015, HAB vs. HAB-EE: p=0.005; Fig. 3.23 B, 3.25 ). No difference 
was found in the number of DCX+ cells between HAB-MM and HAB-EE (HAB-MM 
vs. HAB-EE: p=1.000). Both findings indicate a higher rate of neurogenesis in both 
HAB-MM and HAB-EE mice compared to HAB controls. Images of neurogenesis in 
the DG are shown for BrdU+ cells in Fig. 3.24 and for DCX+ cells in Fig. 3.25.  
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Figure 3.23: Effects of enriched environment (EE) and memantine (MM) injection on 
neurogenesis in HAB mice in the dentate gyrus (DG) of the hippocampus. Effects are shown of 
(A) survival of newly born cells indicated by number of BrdU+ cells and (B) immature neurons 
indicated by the number of DCX+ cells. Data are shown as mean + SEM, (N (HAB) = 7, N (HAB-MM) 
= 5, N (HAB-EE) = 9; * p<0.05, ** p<0.01). BrdU, bromodeoxyuridine; DCX, doublecortin. 
 
 
Figure 3.24: Bromodeoxyuridine (BrdU) images of neurogenesis in the dentate gyrus (DG) of 
the hippocampus. BrdU+ cells in (A) HAB, (B) HAB-MM and (C) HAB-EE mice in the subgranular 
and granular cell layer (GCL) of the DG (indicated by black arrows). Scale bar 100 µm. Mol, molecular 
layer. 
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Figure 3.25: Doublecortin (DCX) images of neurogenesis in the dentate gyrus (DG) of the 
hippocampus. DCX+ cells in (A) HAB, (B) HAB-MM and (C) HAB-EE mice represent cell bodies in 
the subgranular and granular layer of the DG (indicated by black arrows) and the dendrites projecting 
into the granular cell layer (GCL) and the molecular layer (Mol) (indicated by white arrows) of the DG. 
Scale bar 100 µm.  
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4 Discussion 
In this study, we took advantage of the selective breeding of the HAB/LAB anxiety 
mouse model, where HAB mice show high and LAB mice low anxiety-related and 
comorbid depression-like behaviors. This selective, bidirectional breeding was 
established to conserve genetic components that lead to these two extremes in 
anxiety-related behavior. We here were able to converge both extremes towards 
normal behavior using environmental manipulations. In this context, it seems that 
gene x environment interaction (GxE) plays a crucial role for shaping anxiety.  
EE was applied to reduce anxiety of HAB mice, whereas CMS was used to induce an 
anxiogenic effect in LAB mice. Both environmental manipulations were done as 
described previously (Markt, 2012; Sotnikov, 2013). In this study, new batches of 
both manipulations were created from the 45th HAB/LAB generation of our breeding. 
Indeed, EE demonstrated robust anxiolytic effects in HAB mice, which were shown in 
two of three anxiety-related behavioral tests. No difference was observed in 
locomotion and explorative behavior of the OF test (Fig. 3.3). The EE-exposed HAB 
mice exhibited less anxious behavior verified in the validated EPM (Fig. 3.4) and LD 
(Fig. 3.5) behavioral tests.  
On the other hand, in LAB mice CMS treatment induced an anxiogenic effect in the 
EPM test for female mice (Fig. 3.11) and in the LD test for both sexes (Fig. 3.12). For 
LAB mice, also a shift in depression-like behavior was observed. Both sexes 
exhibited higher depression-like behavior after exposure to CMS compared to normal 
LAB controls, which were highly active (Fig. 3.13, 3.14). In the following, different 
approaches were used to reveal effects of environmental manipulation on multiple 
levels, e.g., behavior, gene regulation and neurogenesis. 
 
4.1 Microarray studies 
To assess the level of gene regulation, we first identified new candidate genes that 
showed plasticity of gene expression upon environmental manipulations. Thus, after 
inducing a behavioral change we performed microarray-based gene expression 
profiling to compare the HAB, HAB-EE, LAB and LAB-CMS transcriptomes in the 
BLA.  
Discussion 
90 
 
The BLA has been suggested to function as an integration center between other 
nuclei of the amygdala to react properly to stressors and to mediate phenotypic 
plasticity (Campeau and Davis, 1995). This structure was chosen for analysis since it 
was described to be involved in the regulation of anxiety-related behavior (Felix-Ortiz 
et al., 2013; Wang et al., 2011) and, importantly, to play a critical role in behavioral 
response to environmental manipulations (Sotnikov et al., 2014a). Furthermore, 
studies of Sotnikov et al. (2014b) found differences in the amygdala response to 
predator odor exposure between HAB and LAB mice. These findings were supported 
by an electrophysiological study, where a lower signal propagation was found 
through the amygdala of LAB compared to HAB mice utilizing voltage-sensitive dye 
imaging (Avrabos et al., 2013). Moreover, in clinics, functional neuroimaging showed 
an increased activity of the amygdala in PTSD and phobia patients (Etkin and Wager, 
2007).  
In this study, using a combination of beneficial and adverse environmental 
manipulations and whole genome gene expression profiling, we were able to identify 
novel candidate genes in the BLA potentially involved in the rescue of inborn anxiety-
related behavior of HAB and LAB mice.  
 
Altogether, 138 candidate genes were differentially regulated in HAB vs. LAB, 78 
genes in HAB vs. HAB-EE and 67 genes in LAB vs. LAB-CMS, according to the 
microarray study. 
First of all, for HAB vs. LAB mice, a highly significant difference in the regulation of 
genes was observed. The microarray conducted in generation 45 between HAB and 
LAB animals confirmed the same six candidate genes as detected already more than 
20 generations ago, irrespective of gender, in various brain regions (Czibere et al., 
2011) (Fig. 4.1). Thus, this underlines the strongly fixed genetic background of the 
respective phenotype and the robustness of the trait under basal conditions. This 
clear separation of the two mouse lines bred for anxiety-related behavior is presented 
in the created cluster dendrogram showing the relationship with ‘hclust’ function of R 
(see Fig. 3.6). Out of the 138 highly significant genes, we were focusing on the six 
genes, which were observed to be differentially expressed in microarray experiments 
twice as well as at least once validated by qPCR analysis (Fig. 3.7, Table 3.3). Ctsb, 
Enpp5 and Slc25a17 were higher expressed in LAB compared to HAB mice. In 
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contrast, Abca2, Stx3 and Ttbk1 had a higher expression in HAB mice. Compared to 
the previous microarray (Czibere et al., 2011), Enpp5 showed contradictory results. 
 
 
Figure 4.1: Gene expression profiles confirmed by qPCR of HAB vs. LAB mice in multiple brain 
regions of the HAB/LAB mouse model. Data are presented as mean + SEM, (N = 6-10 per group, T 
p<0.1, * p<0.05, ** p<0.01, *** p<0.001). (Figure adapted from Czibere et al., 2011). 
 
 
Using annotational cluster analysis (http://david.abcc.ncifcrf.gov/) (see Table 3.1), the 
first cluster contained genes contributing to different functions in the mitochondrion, 
so-called mitochondrially active genes. Mitochondria are involved in several different 
functions, like energy metabolism and are an integral part of various cell signaling 
cascades (McBride et al., 2006). Abca2, Ctsb and Slc25a17, three of our identified 
candidate genes, differentially regulated between HABs and LABs, can be classified 
in this cluster. Moreover, Ctsb and Abca2 appeared in one more cluster together 
associated with cytoplasmic or membrane-bounded vesicles. Furthermore, Abca2 
was found in another cluster arrangement together with Ttbk1 in association to 
nucleotide and ATP binding. 
Ctsb was the highlight of the previous transcriptome analysis (Czibere et al., 2011) 
(Fig. 4.1) and showed in the current study the most significant regulation in LAB 
compared to HAB mice (see Fig. 3.7). This can be explained in part by the fact that 
about 90 variations in the sequence of the Ctsb gene were identified varying between 
HAB/LAB mice (Czibere et al., 2011). In that study, Ctsb knock-out mice were 
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behavioral tested, and an effect of Ctsb deficiency on depression-like behavior in 
males and females was detected.  
Recently, a link between administration of a substance ‘poloxamer 407’ on serum 
lipids profiles including Ctsb and anxiety levels was discovered with an increase of 
these cysteine proteases in liver and heart tissues. The higher activity of lipids 
resulted in an increase of anxiety behavior in the EPM test (Korolenko et al., 2013). 
In this case, it was explained to appear as a therapeutic target for atherosclerosis in 
a mouse model of hyperlipidemia and atherosclerosis. 
For Abca2, an ATP-binding cassette (ABC) transporter, in both microarray studies a 
deficiency in LAB compared to HAB mice was found (Fig. 4.1, 3.7). Abca2 was 
suggested to be a therapeutic target in cancer and nervous system disorders such as 
in early onset Alzheimer’s disease or myelin-related disorders (Mack et al., 2008). In 
that review, the contribution of Abca2 as “a mediator of intracellular sterol transport” 
to human diseases was analyzed and described. Furthermore, a Japanese research 
group used a knockout mouse line for Abca2 showing increased environmental 
stress vulnerability and decreased locomotor capabilities (Sakai et al., 2007). 
An interesting gene involved in neurometabolism is Slc25a17, which was described 
to function as a peroxisomal ATP transporter (Agrimi et al., 2012; Visser et al., 2002). 
Ttbk1 is not well-described, however, in the context of anxiety. This gene is found to 
have implications in the pathological phosphorylation of tau in Alzheimer’s disease 
(Lund et al., 2013).  
Furthermore, an impact on metabolism is known for Stx3 (Darios and Davletov, 2006) 
and Enpp5. Stx3 is described to be important as a plasma membrane protein 
required for neurite growth and neural development (Darios and Davletov, 2006). The 
latter gene is counted as one of several ENPP enzymes functioning as significant 
players in various pathological conditions, as well as key regulators of crucial 
physiological signaling pathways such as purine or pyrimidine signaling regulation 
(Masse et al., 2010).  
Thus, all these differentially expressed genes indicate robust basic differences 
between HAB and LAB, most likely also affecting neuronal function finally changing 
and shaping the respective phenotypic differences.  
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For the HAB vs. HAB-EE and LAB vs. LAB-CMS, three out of 14 possible plasticity 
genes detected in the microarray study could be confirmed in subsequent qPCR 
analyses. Since, Fos showed a contradictory regulation between microarray (Fig. 3.8) 
and qPCR analyses (Fig. 3.10), the reason for this discrepancy can be manifold and 
should be addressed in further studies. Foxp2 and Cnksr2 were detected in the 
microarray analysis as differentially regulated, but Foxp2 could not be validated by 
qPCR (Fig. 3.10).  
Interestingly, two validated genes - Gabrq and Cnksr2 - are X-linked. For instance, it 
is known, that syndromes like ADHD or X-linked intellectual disability are linked to 
loci on the X-chromosome (Houge et al., 2012; Vaags et al., 2014). In a recent study, 
the linkage to ADHD was found in the HAB/LAB mouse model, in which the 
hyperactivity of LAB mice was rescued by amphetamine treatment resulting in a 
reduced locomotor activity (Yen et al., 2013). Therefore, further studies regarding 
maternal inheritance might be of great interest.  
It is known that the amygdala is highly connected to cortical structures, e.g., the Cg, 
which appears to be correlated with the formation of anxiety traits (Most et al., 2006; 
Shin and Liberzon, 2010). Therefore, a range of differentially expressed candidate 
genes of plasticity were additionally measured in the Cg using qPCR analysis. No 
significant difference in gene expression was detected (see 3.1.3.6). This indicates 
that in our model the BLA is more likely to play a significant role in environment-
induced plasticity rather than the Cg.  
As our focus laid on environmental manipulation and gene-environment interactions, 
the three differentially expressed candidate genes of plasticity (Fos, Gabrq, Cnksr2) 
are discussed in detail in the following section. 
 
Fos 
 
The first investigated gene Fos showed a significantly higher expression in HAB 
compared to HAB-EE mice in qPCR analysis (see Fig. 3.10). It was detected in the 
microarray experiment, but showed a regulation in the opposite direction. However, 
the data of the qPCR analysis seems more reliable as it is based on two primers and 
not only on one probe. Fos is an ‘immediate early (IE) gene’ and acts as a marker of 
cell activation in earlier stages after an exposure to a stressor/stimulus (Greenberg 
and Ziff, 1984; Hughes and Dragunow, 1995; Sagar et al., 1988). “It has been 
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suggested that it acts as a ‘third messenger’ molecule in signal transduction systems, 
where it would couple short-term intracellular signals elicited by a variety of 
extracellular stimuli to long-term responses by altering gene expression” (Reddy et 
al., 1988; Sagar et al., 1988). 
A high distribution density was shown all over the whole brain, however, basal 
expression is relatively low (Sagar et al., 1988) (http://www.brain-map.org/, 
20.05.2015).  
Malik and colleagues (2014) suggested that the transcription factor FOS controls 
enhancer function reflected by regulation of activity-dependent gene expression. This 
can occur by binding to similar sites in gene enhancers (Malik et al., 2014). Two 
phases of gene transcription in reaction to neuronal stimulation are described. First of 
all, within minutes as early phase after excitation (stimulation) ‘IE genes’ are 
transcribed (Greenberg and Ziff, 1984). In the later phase, arising over hours, genes, 
which are responsible for encoding ‘plasticity-related products’, can be turned on. 
Several previous studies on HAB/NAB/LAB mice grown up in standard or modified 
environmental conditions reported different c-Fos activity after applying different 
stressors to map c-fos expression. Muigg et al. (2009) used unavoidable exposure to 
the open arms of the EPM test and detected strongly facetted c-fos expression 
phenomena. Another study by Sotnikov et al. (2014b) showed an increased c-fos 
expression in several brain regions after trimethylthiazoline (TMT) - a synthetic fox 
fecal odor - exposure. In this study, authors found a higher basal c-fos expression in 
HAB than in HAB-EE mice only in the hippocampus using in situ hybridization. After 
exposure to TMT, a significantly lower expression in the BLA was observed in the 
EE-treated mice, which we found here using qPCR already at basal conditions. All 
this data are consistent with reduced amygdalar Fos in EE rats induced by aversive 
conditioning (Nikolaev et al., 2002). Also higher expression of this gene was 
observed in the amygdala of HAB compared to LAB mice. Although our data did not 
show significant differences in the comparison between LAB and LAB-CMS under 
basal condition (see Fig. 3.8), after exposure to TMT, LAB-CMS mice showed an 
increase in c-fos in the amygdala and PVN (Sotnikov, 2013). Moreover, these results 
are in line with previous electrophysiological studies (Avrabos et al., 2013). Thus, 
HAB-EE mice showed low amygdala activity, as it was observed in LAB mice. 
Inversely, CMS-experienced and HAB mice exhibited increased activity. This is in line 
with our data, in which HAB-EE mice showed reduced anxiety behavior as well as 
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lower Fos expression in the BLA (Sotnikov et al., 2014b). All these findings describe 
an ‘IE gene’, which is expressed relatively low in most CNS areas at basal condition, 
but increases after exposure. We studied long-term EE modifications and found a 
higher basal level of Fos after several weeks of EE in comparison to standard-
housed HAB mice. Hence, constant exposure to external stimuli, like EE, can have 
an impact on Fos expression. Thus, this observed difference in gene expression 
suggests Fos as a candidate gene of plasticity showing an effect in long-term 
exposure. In addition, constantly increased expression of Fos might trigger further 
mechanisms, like neurogenesis (Sah, 2012), which might alter brain function and will 
be discussed later.  
 
Gabrq 
 
Another gene expressed lower in HAB-EE compared to HAB mice (see Fig. 3.10), is 
a gene coding for the theta subunit of GABAA receptors (Gabrq). Its sequence has 
the highest similarity with the ß1 subunit. A dysregulated GABA system is implicated 
in the pathology of anxiety disorders (Nemeroff, 2003; Nutt and Malizia, 2001).  
GABAA receptors have been shown strongly to be selective, and variations of GABAA 
receptor genes are influencing a component of the bipolar disorder phenotype 
(Craddock et al., 2010). Several studies identified that GABA, the major inhibitory 
neurotransmitter in the CNS, has an important role in depression and anxiety (Kalueff 
and Nutt, 2007). Avrabos and colleagues (2013) detected changes in EE-induced 
neuronal activity propagation caused by GABA receptor-mediated inhibition. 
According to the Allen Institute for Brain Science, Gabrq has a high expression in the 
hypothalamus in an adult mouse brain detected by immunohistochemistry 
(http://www.brain-map.org/, 20.05.2015). In human and monkey brain, Gabrq is 
shown to be distributed in the amygdala, hippocampus and further areas, whereas in 
the rat brain it is highly expressed in the striatum and locus coeruleus (Bonnert et al., 
1999; Sinkkonen et al., 2000). It is known that the medial hypothalamus receives 
efferent signals from the CeA to activate the sympathetic nervous system. Ranna 
and colleagues (2006) found out that θ subunits added to α3β1 GABAA receptors can 
be relevant for new drug targets. Gabrq is an X-linked gene and was identified in a 
study of females with Autism Spectrum Disorder to have a functional variant in this 
disease (Butler et al., 2015).  
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Not much is known about the function of this θ subunit in mouse brain, since it was 
detected with different properties/high level of divergence within species (Sinkkonen 
et al., 2000). The co-assembly of θ with αβγ revealed an affinity decrease of GABA in 
recombinant cells and has a benzodiazepine modulatory site (Bonnert et al., 1999). It 
is described that BZs potentiate the actions of GABA at the GABAA receptor to 
function as an anxiolytic drug (Nemeroff, 2003; Nutt and Malizia, 2001). BZs are 
modulating the GABAA receptor allosterically and are known to be the most used 
drug treatment for acute anxiety (Macaluso et al., 2010; Singewald et al., 2015). 
Acute activation is therefore linked to a directly involvement in anxiety-regulating 
mechanisms, whereas SSRIs have a delayed effect and require time to create 
plasticity changes (Olivier et al., 2013). With these changes of the receptor, the 
affinity for GABA can be increased (Nemeroff, 2003; Ballenger, 1998). In our 
findings, the HAB mice, which represent the high anxiety phenotype, show higher 
expression of the θ subunit gene. Therefore, a dysfunction in the GABA affinity might 
exist. EE mice have less of this subtype, which could lead to a higher GABA affinity 
comparable to the way BZs act (see chapter 1.8). In our cluster analysis, Gabrq is 
represented in two enriched clusters associated with plasma membrane/receptor 
complex and postsynaptic membrane function (see Table 3.2). This gives a hint that 
in plasticity receptor complexes and membrane it may have a critical role in 
modulating anxiety, and minor subtypes have a relevant influence in “physiology and 
as pharmacological targets” (Ranna et al., 2006). Until now, these findings could 
guide future approaches for developing new selective compounds for this receptor 
subtype.  
 
Cnksr2 
 
In our study, Cnksr2 was detected in both microarray comparisons (HAB vs. HAB-
EE, LAB vs. LAB-CMS; see Fig. 3.8 and 3.9) in the BLA. Not much is known about 
the functions of Cnksr2. The connector enhancer of kinase suppressor of Ras 2 is 
functioning as an adaptor protein or regulator of the mitogen-activated protein kinase 
(MAPK) pathways downstream from Ras. It is suggested that CNK2 is responsible for 
including various regulatory pathways to get an appropriate biological response to 
external stimuli (Bumeister et al., 2004). This gene product is induced by vitamin D 
and inhibits apoptosis in certain cancer cells. It may also play a role in ternary 
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complex assembly of synaptic proteins at the postsynaptic membrane and coupling 
of signal transduction to membrane/cytoskeletal remodeling (http://string-db.org/; 
15.06.2015). The gene was found to be highly expressed in different brain regions 
like amygdala, hippocampus and cerebellum (Houge et al., 2012).  
In a study with male patients, the deficiency in Cnksr2 is a marker for a special 
disease characterized by attention-deficit/hyperactivity, intellectual and language 
deficits (Vaags et al., 2014). Earlier studies showed that many similarities to human 
ADHD appear in LAB mice based on their behavior and their response to 
pharmacological treatment (Yen et al., 2013). A significant difference was detected in 
the microarray study and was validated in the LAB vs. LAB-CMS comparison 
determined by a higher expression in LAB mice (see Fig. 3.10). According to these 
findings, LAB mice should have an absence or a lower expression of Cnksr2 gene as 
they are handled as a potential novel model for the complex disorder ADHD.  
The main contribution of MAPKs is acting in the network of signal transduction 
pathways, in which they are managing major developmental changes or acute 
responses to hormones (Pearson et al., 2001).  
A specific kinase is described to be activated by different stressors and is entailed in 
various dysfunctions like Alzheimer’s disease (Obata et al., 2000). Cnksr2, as a 
possible regulator of the MAPK signaling pathway, showed plasticity for 
environmental changes. Here, stressed LAB mice exhibited a lower expression and 
therefore, this gene can be possibly involved in the action of signal transduction in 
our mouse model. It is also known that c-fos (see Fos) has an important role in the 
biological process of stress-activated MAPK cascades (Tanos et al., 2005). c-fos is 
one of the activated genes in cellular reactions in transcription induced by Ras 
(Zhang and Liu, 2002). As a consequence, the identification of the exact ways of 
action of MAP kinase might be a promising approach to determine possible 
mechanisms shaping anxiety in the HAB/LAB mouse model.  
 
In conclusion, the microarray is consistent in detecting differences in gene 
expression, however, complementary approaches for validation have to be 
performed. The detailed molecular mechanisms how these genes can be involved in 
changes of anxiety-related behavior remain largely unknown. In the following section, 
we tried to assess the critical question if changes in plasticity genes (driven by 
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environmental modifications) can be transmitted to their offspring, thus possibly 
affecting behavior in upcoming generations. 
 
4.2 Transgenerational transmission 
In these series of experiments, we investigated if anxiogenic effects of adverse 
environmental experiences in one generation may profoundly impact behavior of 
subsequent generations. To assess whether transgenerational transmission of CMS-
induced behavioral changes occur in both males and females, we analyzed offspring 
up to generation F2 in a battery of behavioral tests. Thus, we used two tests to 
evaluate anxiety-related behavior (EPM, LD tests) as well as two tests to measure 
depression-like behavior (TST, FST). These tests were chosen since stable and 
reliable differences were observed for the parental generation after environmental 
manipulations. 
In the parental generation, CMS induced reduced locomotive behavior, anxiogenic 
and pro-depressive effects, which were observed overall in female mice. In male 
mice, a difference was shown in only one out of two tests. These slight discrepancies 
might arise from the fact that different behavioral tests measure different aspects of 
anxiety-related and depressive-like behavior (Belzung and Griebel, 2001; Sartori et 
al., 2011). These CMS-induced effects were also seen partially in the F1 generation 
(CMS-CMS) and F2 generations, where all 3 generations (CMS-CMS-CMS) were 
exposed to environmental stimuli (see Fig. 2.8). This anxiogenic and pro-depressive 
effect of CMS corroborates the robustness and reproducibility of our paradigm. As 
every generation was directly exposed to CMS – parents, embryo (F1) and embryo’s 
gametal cells (F2) – an intergenerational effect could be considered, whereas a 
transgenerational effect in this groups has to be excluded according to its definition 
(Daxinger and Whitelaw, 2012; Lightman and Conway-Campbell, 2010; Skinner, 
2014). We used this line to verify if the CMS-induced effects were stable across 
generations, but no additive effect was entailed. A so called multigenerational 
exposure is shown here, which describes the individual phenotypic behavior of 
environmental exposure at each generation. This in turn can promote epigenetic 
programming (Skinner, 2008).  
In contrast, in the LD test, one out of four conducted behavioral tests, a possible 
transgenerational effect in generation F2 was measured (CMS-Co-Co, see Fig. 3.19). 
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Female mice (CMS-Co-Co) exhibited a significant anxiogenic effect in several 
parameters of this test (see Fig. 3.19 A and Fig. 3.19 B), whereas for male mice the 
effect is only seen in the latency to the first entry to the light compartment (see      
Fig. 3.19 C). Different mechanisms and inheritance could be the reason, thus in our 
study mothers and fathers were exposed to CMS. At this point, the impact of lifelong 
maternal or paternal exposures to progeny neurodevelopment is less studied, 
whereas perturbations on pregnant females are known to influence fetal development 
(reviewed in Bale et al., 2010). 
On the one hand, it is known that a transgenerational effect could be transmitted 
through the paternal lineage. Several studies suggested a partial contribution of 
“father’s stressful experiences” to the “individuals’ risk of stress-related disorders” 
(Dietz and Nestler, 2012). Dias and Ressler revealed that parental olfactory 
experience was transgenerationally inherited via parental gametes in F2 generation. 
This was additionally shown by cross-fostering (Dias and Ressler, 2014). Paternal 
transmission after chronic social defeat stress was reported by another study (Dietz 
et al., 2011). Modest changes are likely to be transmitted epigenetically from father to 
its F1 male and female offspring. The transgenerational transmission of stress 
susceptibility traits in the progeny of CMS mice implies an epigenetic change in the 
paternal germline (Dietz et al., 2011).  
On the other hand, Franklin et al. (2010) reported a transgenerational transmission of 
the negative impact of early stress caused by maternal separation. Authors 
suggested that changes in DNA methylation altered gene expression in the germline 
of early-life stressed males. A relation to modifications of promoters, for example of 
Crhr2, was found. Thus, transmission may occur through males or females, offspring 
can be influenced in a sex-dependent manner. This phenomenon of sex-dependent 
expression of a trait was also shown in humans (Pembrey et al., 2006; Vige et al., 
2008).  
Numerous studies highlight the negative effect of stress on breeding success, and 
that stressors interfere with pregnancy (deCatanzaro and Macniven, 1992; DeSantis 
and Schmaltz, 1984; Ebensperger, 1998). However, no effect was observed 
regarding breeding success between CMS and Co groups (see Table 3.8) in our 
study.  
Maternal behavior is supposed to play an important role in transmission across 
generations (Huot et al., 2004; Schmauss et al., 2014; Siegmund et al., 2009). It has 
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also been suggested that behavioral deficits can be transmitted through females 
independently of maternal care as well as not concerned by cross-fostering (Weiss et 
al., 2011). This is in line with previous studies on maternal behavior and cross-
fostering paradigms, which have reported that LAB mice/rats show, in general, less 
maternal care compared to HAB mice/rats (Kessler et al., 2011; Wigger et al., 2001). 
These results already indicated that the different anxiety-related behavior in HAB vs. 
LAB rats and mice was rather defined genetically than postnatally (Landgraf and 
Wigger, 2002).  
Several studies provided evidence that drug treatments altering, e.g., epigenetics, 
can reverse or prevent inter- and transgenerational effects on future generations 
(Schmauss et al., 2014; Xiong et al., 2015). Interestingly, although specific traits 
cannot be expressed clearly by parents, they can be transmitted and expressed by 
their offspring. This phenomenon shows that mice can function as ‘silent’ or 
asymptomatic carriers of certain behavioral changes (Franklin et al., 2010). Similar 
findings are reported in humans, but the mechanisms behind remain not well 
understood (Kim et al., 2009; Roseboom et al., 2006).  
 
In addition to assess behavioral changes after stress, basal CORT was measured in 
generation F2 to evaluate the relation of basal HPA activity to anxiety. It is known 
that stress and HPA axis are critically involved in environmental induced changes 
(Mormede et al., 2002). In our study, we observed a significant difference in the basal 
plasma CORT for male mice between the four groups, which was not shown for 
female mice (see Fig. 3.20). The highest basal CORT levels were revealed in the 
group of all three stressed generations. Accordingly, the level was reduced in the Co-
Co-Co group as well as more decreased in the group of stressed grandparents 
(CMS-Co-Co) and parents (CMS-CMS-Co). These findings indicate that CMS has 
induced different HPA axis regulation already at basal level. Our results are in 
keeping with a previous study by Sotnikov et al. (2013), which reported significantly 
higher basal CORT levels in stressed compared to non-stressed mice, delayed HPA 
reactivity and stronger feedback regulation. Reduced CORT levels were observed in 
all unstressed groups compared to the CMS-treated group in all three generations. 
Only in male mice, the groups, where the parents (F1) or grandparents (P) 
experienced one CMS treatment cycle, CORT levels were even lower compared to 
the Co-Co-Co group. This might hint to an adaptation to stress over the generations. 
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A previous study investigated the influence of chronic stress during adolescence of 
male mice before breeding (Rodgers et al., 2013). Authors showed a reduced HPA 
axis responsiveness as well as changes in sperm microRNA content induced by 
germ cell epigenetic reprogramming. An additive effect of CMS throughout 
generations was observable in F2 mice on the level of basal CORT. More recently, 
Dietz and colleagues found an increased baseline plasma level of CORT in F1 male 
offspring of chronically defeated fathers (Dietz et al., 2011). Thus, our results in the 
F2 generation are comparable with the CMS-CMS-CMS group. Like the results 
described here, previous studies also reported that stress in the parental generation 
can alter the stress reactivity of their progeny (Bertram et al., 2008; Matthews and 
Phillips, 2010; Rodgers et al., 2013). Either increased or decreased dysregulation in 
the stress reactivity system can be indicative of different abilities to respond 
appropriately (Xiong et al., 2015). 
In mice, the postnatal development of the HPA axis is divided into two phases. The 
first one, lasting from PND 1 until PND 12, is indicated by low basal CORT, a higher 
expression of Crh in the PVN, as well as no reaction to stress in promoted CORT or 
ACTH levels (Schmidt et al., 2002). The second phase, until PND 16, showed higher 
CORT levels, a decreased Crh expression, a high GR expression in the 
hippocampus and a response to mild stressors (reviewed in Schmidt et al., 2003). 
Thus, as the different central regulators (Crh, Crhr1, GR) of the HPA axis displayed 
different expression levels, we were interested in their expression in our 
transgenerational experiment. Only a correlation between Crhr1 expression and 
anxiety-related behavior observed in the parameter ‘percentage time spent in the 
light compartment’ of the LD test was found for the male CMS-Co-Co group in the 
BLA (see Fig. 3.21). Remarkably, this corroborates our transgenerational findings in 
the LD test. More anxious mice have a higher expression of Crhr1. As described 
earlier by Sotnikov et al. (2014b), Crhr1 was found to be involved in trait anxiety. A 
higher expression of Crhr1 mRNA was observed in the CMS-treated group, but not of 
the ligand CRH, which is in line with our results. Furthermore, this phenomenon was 
well-discussed in Sotnikov (2013), and it is known that the Crhr1 is largely expressed 
in the BLA, whereas Crh was found in the CeA (Kühne et al., 2012; Van Pett et al., 
2000). Previous studies have reported the link between the dysregulation of the Crh 
system and the development and maintenance of stress-related disorders (de Kloet 
et al., 2005; Holsboer, 1999; Holsboer and Ising, 2008). The limbic Crhr1 conveys 
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anxiety-related behavior and hormonal adaptation to stress (Müller et al., 2003). 
Furthermore, a study found a bidirectional role of Crhr1 in anxiety. On the one hand, 
transmission of anxiogenic stimuli was shown in the amygdala and the hippocampus 
in glutamatergic neurons, whereas in midbrain dopaminergic neurons the anxiety-
related behavior and in the PFC the dopamine release was decreased (Refojo et al., 
2011). In addition, Weiss and colleagues (2011) found a decreased Crhr2 expression 
in the amygdala and hypothalamus in early life stressed females. Hence, the critical 
involvement of amygdala in anxiety and stress-like responses is verified.  
These findings reveal a strong influence of Crhr1 in the BLA and in HPA axis 
regulation, but it might not have a high impact on anxiety-related behavior in one 
generation. PVN is a key structure in the HPA axis and Yin Yang 1 (YY1) is the 
transcription factor suggested to play a possible role in stress-related disorders 
(Sotnikov et al., 2014a). No correlation between expression levels and anxiety-
related behavior in the PVN and for YY1 was measured. Accumulating evidence 
suggests that neuroendocrine responses to stress can be transmitted to subsequent 
generations, which is also supported by our results.  
 
These experiments highlight that the interaction of environmental and epigenetic 
factors with genetic predisposition plays an important role in the onset of psychiatric 
disorders. Environmental manipulations (e.g., stress) together with existing genetic 
variation can cause a new phenotype, which can be fixed in subsequent generations 
and can influence pathological phenotypes of future generations. Adaptive responses 
can arise much faster in reaction to environmental stimuli without waiting “for the 
occurrence of mutation, which, in the original genetic background, mimics the 
response well enough to enjoy a selective advantage” (Tost, 2008). Thus, this rapid 
adaptation is an evolutionary advantage of transgenerational epigenetic inheritance.  
 
As shown so far, shifts in anxiety of both extremes (HAB, LAB) by environmental 
manipulations (EE, CMS) towards ‘normal behavior’ are connected to distinctive 
changes in gene expression, as for the proposed candidate genes of plasticity, like 
Fos, Gabrq or Cnksr2. These shifts along the anxiety continuum can also influence 
offspring of the treatment-exposed animals. As the described candidate genes are 
mainly characterized as genes related to neuronal activity and cellular transcriptional 
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activity, neurogenesis, that is known to play a significant role in disorders concerning 
anxiety-related phenotypes, might also be affected by the environmental treatments.  
4.3 Neurogenesis 
Changes in anxiety-related behavior appear to be closely associated with changes in 
hippocampal neurogenesis, whereas modulation of enhanced depression-like 
behavior seems to be regulated by neurogenesis-independent mechanisms (Sah, 
2012; Sah et al., 2012). We investigated a relationship and link between reduced 
anxiety in HAB mice after EE and neurogenesis, additionally using a pharmacological 
approach. A recent study showed that MM treatment increases neurogenesis in mice 
(Akers et al., 2014) and is used as an augmentation therapy for anxiety disorders 
(Schwartz et al., 2012). Therefore, we were interested if MM could increase 
neurogenesis and in parallel show anxiolytic effects in our genetically predisposed 
anxiety mouse model in a similar way as EE treatment does. Thus, various 
behavioral tests and immunohistochemistry verifications were taken to assess 
behavioral and neurogenesis effects. Indeed, significant anxiolytic effects of HAB 
mice treated with MM or EE were shown in the LD test (see Fig. 3.22 B), as well as 
increased neurogenesis indicated by increased number of BrdU+ cells and DCX+ 
cells in the DG (see Fig. 3.23). BrdU is a thymidine analogue, which is incorporated 
into the DNA in dividing cells and can be detected immunohistochemically in their 
progeny (Kuhn, 1996). BrdU cells give an indication of the number of newly born 
cells, whereas the number of DCX+ cells shows the number of immature neurons. 
Our results demonstrate reduced anxiety-related behavior of the EE- and MM-treated 
mice reflected in the LD test. No differences were observed in locomotion measured 
in the OF test (see Fig. 3.22 A) nor in depression-like behavior (see Fig. 3.22 C). 
Our data are consistent with an earlier study performed by Sah et al. (2012) showing 
an anxiolytic effect of EE and an increase in neurogenesis in HAB mice. Thus, no 
effect of EE on depression-like behavior was also demonstrated in this case. This 
suggests that neurogenesis appears to be related to anxiety-related rather than 
depression-like behavior.  
Several studies observed the interplay of EE and increased neurogenesis (Hosseiny 
et al., 2014; Kempermann et al., 1997), which we could validate in our anxiety mouse 
model, as well as the alteration of neurogenesis by MM treatment. Experience-
dependent neuroanatomical plasticity caused by environmental or by 
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pharmacological changes is known to have an impact on neurogenesis (Cameron et 
al., 1995; Cummins et al., 1973; McEwen, 1996). Revest and colleagues (2009) 
showed that a deficit of hippocampal neurogenesis enhanced anxiety-related 
behaviors as revealed in a series of behavioral tests using avoidance of threatening 
situations.  
To assess whether EE and MM treatment can complement each other, we performed 
an EE or pharmacological treatment to HAB mice. Interestingly, treatment with MM 
decreased anxiety-related behavior observed in the LD test as well as increased 
neurogenesis indicated by a higher number of newly born and immature neurons. It 
is suggested that MM, a noncompetitive NMDA glutamate receptor antagonist, is 
relevant for the glutamate-GABA balance. Both glutamate, an excitatory 
neurotransmitter and GABA, an inhibitory neurotransmitter, are critically involved in 
the development of the pathophysiology of anxiety (Cortese and Phan, 2005; Kalueff 
and Nutt, 2007). MM functions via decreasing glutamate activity, which can be 
followed by reduced anxiety. Schwartz et al. (2012) suggested that in a patient, 
treated with MM, a lowered level of glutamate is present and therefore, the own 
GABA system has the power to decrease the symptoms of generalized anxiety 
disorder. Hippocampal neurogenesis and the expression of GABAA receptors are 
inhibited and reduced by early life stress (Mirescu et al., 2004). Another study found 
a deficit in adult SGZ neurogenesis and an anxiety-related and depressive-like 
condition, which is possibly caused by a moderate reduction of GABAA receptor 
function in immature neurons (Earnheart et al., 2007). The balance of glutamate and 
GABA activity seems to play a crucial role in the development of several mood 
disorders such as GAD and depression.  
In this study, we used i.p. injection as described by Akers et al. (2014), since it has 
likely different pharmacodynamical effects to oral administration. Here, no negative 
effects on the condition of the mice were observed, although we injected several 
times i.p. Other studies indicate that high doses of oral MM administration in mice 
enhance spatial learning and alleviates anxiety (Minkeviciene et al., 2008). This 
information could be a relevant factor to further pharmacological studies and drug 
development to establish a compatible treating method. Our data supports the 
possible augmentation therapy of MM for patients suffering from anxiety or 
depression (Ferguson and Shingleton, 2007; Schwartz et al., 2012) and for patients 
being less responsive to usual antidepressant anxiolytics. Therefore, the present 
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study suggests MM or a pharmacological analog as a potent agent to reduce anxiety, 
potentially even in clinically relevant settings. The similar results that we could obtain, 
using the MM and EE approaches on HAB mice, point to a strong common 
underlying mechanism, as with both treatments, neurogenesis was increased and 
anxiety-related behavior decreased. Thus, we could demonstrate a direct connection 
of EE and neurogenesis, and MM and anxiety-related behavior. These are two 
connections that have been mentioned by studies before separately. However, the 
underlying processes remain still to be elucidated. 
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5 Conclusion and Perspectives 
In summary, our results clearly showed that environmental modifications from both 
extremes of an anxiety continuum could be shifted in the direction of normal 
behavior, and, in addition to the previously found Crhr1 (Sotnikov et al., 2014a), three 
other genes (Fos, Gabrq, Cnksr2) in the BLA should be considered for the category 
of candidate genes of plasticity.  
In the second part, a transgenerational inheritance effect of CMS treatment could be 
confirmed based on an investigation of anxiety-related and depression-like 
behavioral phenotypes of two following generations.  
Finally, using a pharmacological approach, we could show that anxiolytic effects of 
EE or MM could be closely associated with increased hippocampal neurogenesis. 
 
The findings presented in this study implicate that GxE can be observed on different 
pathways/network levels: neuronal network (neurogenesis), neuropeptide systems 
(CRH), genetic and transcriptional (Fos) levels. These data provide the basis for 
diverse consecutive experiments. As often discussed, GxE has an important role in 
the etiology of anxiety disorders, which is reflected in changes of the phenotype, 
whereas a genetic background comprising all genes and non-coding sequences 
cannot be altered. Therefore, more studies in the direction of analyzing the 
involvement of molecular actions and their implications have to be performed to gain 
a better knowledge about individual reactions on GxE. 
 
First of all, after the confirmation of the genetically stable predisposition of HAB and 
LAB mice, future experiments should focus on the detailed examination of the 
differentially expressed candidate genes of plasticity. For Cnksr2 and Gabrq, in situ 
hybridization can be used to detect higher or lower expression levels of the candidate 
genes. This technique can give information about the distribution of expression 
patterns in different brain regions after environmental manipulations. Moreover, 
studies should investigate the long-term changes of Fos and the mechanisms 
behind. Furthermore, the biological information level is limited by mRNA expression 
analysis. Therefore, it is necessary to look further into cellular processes. The 
amount of mRNA was measured in this study, but nothing is known about the 
functionality of the respective proteins. Immunostaining techniques, like Western 
Conclusion and Perspectives 
108 
 
blotting, could be used to investigate absence or presence of a protein of interest, its 
sub-cellular localization and changes in its expression, degradation or its 
posttranslational modifications, e.g., phosphorylation patterns. 
Thus, while the microarray study focused on environment-induced changes, the 
epigenetic factors contributing to these changes remain largely unknown. Studies on 
DNA methylation, histone modifications, chromatin structure, and non-coding RNA, 
which are counted to epigenetic processes, add valuable information to further 
analyses.  
 
Second, this study suggests a CMS-induced transgenerational transmission to 
subsequent generations. Since we stressed both sexes and mated them, further 
analyses should focus on paternal vs. maternal influences to reveal gender effects 
separately. A method of choice for future studies might be to investigate paternal 
stress exposure on sperm microRNA content (Rodgers et al., 2013). Furthermore, 
the correlation/association of Crhr1 to anxiety-related behavior points to an effect of 
inheritable epigenetic factors. Therefore, future studies should look closer on 
epigenetic reprogramming, e.g., DNA methylation, transmission and especially the 
influence of Crhr1 and the candidate genes of plasticity (Fos, Gabrq, Cnksr2) 
investigated in this study.  
 
Third, it will be an issue of future studies to determine the further clinical use of 
proneurogenic treatment (e.g., MM) in psychiatric disorders. In addition to changes in 
neurogenesis, the influence of MM on gene expression levels in various brain regions 
might be a further area of investigation.  
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